| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO transferase activity | 2.79e-07 | 36 | 251 | 7 | GO:0019789 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 1.65e-06 | 17 | 251 | 5 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 1.65e-06 | 17 | 251 | 5 | GO:0019198 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 4.01e-06 | 20 | 251 | 5 | GO:0061665 | |
| GeneOntologyMolecularFunction | nucleoside-triphosphatase regulator activity | TBC1D9B IQSEC2 DENND2B ASAP1 FARP2 ARFGAP3 HPS4 RGPD3 ARHGAP29 AGFG1 PLCG1 RGPD5 RANBP2 RGPD8 DOCK8 RALGAPA2 TBC1D17 THY1 PLCE1 | 2.44e-05 | 507 | 251 | 19 | GO:0060589 |
| GeneOntologyMolecularFunction | GTPase regulator activity | TBC1D9B IQSEC2 DENND2B ASAP1 FARP2 ARFGAP3 HPS4 RGPD3 ARHGAP29 AGFG1 PLCG1 RGPD5 RANBP2 RGPD8 DOCK8 RALGAPA2 TBC1D17 THY1 PLCE1 | 2.44e-05 | 507 | 251 | 19 | GO:0030695 |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 4.74e-05 | 103 | 251 | 8 | GO:0004725 | |
| GeneOntologyMolecularFunction | GTPase activator activity | TBC1D9B ASAP1 ARFGAP3 RGPD3 ARHGAP29 AGFG1 RGPD5 RANBP2 RGPD8 RALGAPA2 TBC1D17 THY1 | 2.27e-04 | 279 | 251 | 12 | GO:0005096 |
| GeneOntologyMolecularFunction | channel regulator activity | 3.67e-04 | 174 | 251 | 9 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 4.16e-04 | 177 | 251 | 9 | GO:0141108 | |
| GeneOntologyMolecularFunction | heparan sulfate N-deacetylase activity | 4.68e-04 | 3 | 251 | 2 | GO:0102140 | |
| GeneOntologyMolecularFunction | ionotropic glutamate receptor binding | 4.84e-04 | 52 | 251 | 5 | GO:0035255 | |
| GeneOntologyMolecularFunction | calcium ion binding | DCHS2 TBC1D9B ADGRV1 ITPR1 MICU1 USP32 PCDH15 NID1 PLCG1 NAALADL1 PCDHGA4 FAT3 PCLO ANXA7 PCDHB14 PCDHB11 PCDHA1 SELENON PCDHB16 CD93 VCAN | 5.35e-04 | 749 | 251 | 21 | GO:0005509 |
| GeneOntologyMolecularFunction | glutamate receptor binding | 5.49e-04 | 81 | 251 | 6 | GO:0035254 | |
| GeneOntologyMolecularFunction | complement binding | 6.65e-04 | 32 | 251 | 4 | GO:0001848 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 6.68e-04 | 189 | 251 | 9 | GO:0004721 | |
| GeneOntologyMolecularFunction | heparan sulfate sulfotransferase activity | 7.98e-04 | 15 | 251 | 3 | GO:0034483 | |
| GeneOntologyMolecularFunction | [heparan sulfate]-glucosamine N-sulfotransferase activity | 9.29e-04 | 4 | 251 | 2 | GO:0015016 | |
| GeneOntologyMolecularFunction | N-acetylglucosamine deacetylase activity | 9.29e-04 | 4 | 251 | 2 | GO:0050119 | |
| GeneOntologyMolecularFunction | low-affinity IgG receptor activity | 9.29e-04 | 4 | 251 | 2 | GO:0019772 | |
| GeneOntologyMolecularFunction | eukaryotic initiation factor eIF2 binding | 9.29e-04 | 4 | 251 | 2 | GO:0071074 | |
| GeneOntologyMolecularFunction | PDZ domain binding | 9.40e-04 | 123 | 251 | 7 | GO:0030165 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 1.04e-03 | 162 | 251 | 8 | GO:0099106 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on ester bonds | EYA4 LRRIQ4 EYA1 NDST3 FASN PTPRA PTPRD PTPRZ1 PGAP1 PLCG1 DAGLB NDST1 RBBP8 POLE PIWIL4 PTPRU DICER1 PTPRT ARSB DUSP16 PLCE1 | 1.37e-03 | 807 | 251 | 21 | GO:0016788 |
| GeneOntologyMolecularFunction | protein domain specific binding | HIVEP1 NFASC MDM2 ITPR1 JAK2 KIDINS220 ZFYVE9 ARHGAP29 KCNN2 KIF14 FGFR1 SHISA6 ESPN RELA DICER1 SLC9A3 EGR2 PLEKHA1 CABIN1 SRRM2 SON EXOC4 | 1.63e-03 | 875 | 251 | 22 | GO:0019904 |
| GeneOntologyBiologicalProcess | cell junction organization | MYO5B HIPK1 IQSEC2 MPDZ NFASC GRHL2 ZDHHC8 CHRNA7 ASAP1 CACNG2 PTPRA PTPRD FGFR1 CHRFAM7A SHISA6 ANK2 ANK3 PCLO PCDHB14 PCDHB11 APC LRRC4C GRM6 SEZ6L2 PTPRT PCDHB16 THY1 PKP3 CAPRIN2 SNAI1 PHLDB2 SEZ6L | 4.34e-07 | 974 | 254 | 32 | GO:0034330 |
| GeneOntologyBiologicalProcess | protein sumoylation | 2.58e-06 | 71 | 254 | 8 | GO:0016925 | |
| GeneOntologyBiologicalProcess | cilium assembly | MAK TBC1D9B TOGARAM1 KIF24 ASAP1 FSIP2 ALMS1 FAM161A PCDH15 FAM149B1 IQUB CFAP47 IFT22 TBC1D17 C2CD3 DNAH17 CFAP74 TEKT4 MPHOSPH9 | 2.82e-06 | 444 | 254 | 19 | GO:0060271 |
| GeneOntologyBiologicalProcess | neuron development | SCN11A ERCC6 MYO5B TPRN MPDZ NFASC ADGRV1 MDM2 WNK1 CSMD3 CHRNA7 ASAP1 ITPR1 FARP2 JAK2 KIDINS220 PTPRD ALMS1 PTPRZ1 VPS13A PCDH15 FGFR1 CHRFAM7A NDNF ANK3 FAT3 APC LAMB1 LRRC4C DICER1 ARSB THY1 KLF7 EGR2 TMEM132E CAPRIN2 RORB EIF2AK4 CUX1 | 4.06e-06 | 1463 | 254 | 39 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell projection assembly | MAK TBC1D9B PDGFRB TOGARAM1 KIF24 ASAP1 FSIP2 ALMS1 FAM161A PCDH15 FGFR1 FAM149B1 IQUB ESPN CFAP47 IFT22 APC TBC1D17 C2CD3 DNAH17 CFAP74 TEKT4 MPHOSPH9 PLCE1 | 4.53e-06 | 685 | 254 | 24 | GO:0030031 |
| GeneOntologyBiologicalProcess | mechanoreceptor differentiation | 5.61e-06 | 104 | 254 | 9 | GO:0042490 | |
| GeneOntologyBiologicalProcess | positive regulation of Schwann cell differentiation | 7.32e-06 | 4 | 254 | 3 | GO:0014040 | |
| GeneOntologyBiologicalProcess | cilium organization | MAK TBC1D9B TOGARAM1 KIF24 ASAP1 FSIP2 ALMS1 FAM161A PCDH15 FAM149B1 IQUB CFAP47 IFT22 TBC1D17 C2CD3 DNAH17 CFAP74 TEKT4 MPHOSPH9 | 7.67e-06 | 476 | 254 | 19 | GO:0044782 |
| GeneOntologyBiologicalProcess | neuron projection development | SCN11A ERCC6 MYO5B TPRN MPDZ NFASC ADGRV1 MDM2 CSMD3 CHRNA7 ASAP1 ITPR1 JAK2 KIDINS220 PTPRD ALMS1 PTPRZ1 VPS13A PCDH15 FGFR1 CHRFAM7A NDNF ANK3 FAT3 APC LAMB1 LRRC4C DICER1 ARSB THY1 KLF7 EGR2 CAPRIN2 EIF2AK4 CUX1 | 8.52e-06 | 1285 | 254 | 35 | GO:0031175 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection assembly | MAK TBC1D9B PDGFRB TOGARAM1 KIF24 ASAP1 FSIP2 ALMS1 FAM161A PCDH15 FAM149B1 IQUB ESPN CFAP47 IFT22 APC TBC1D17 C2CD3 DNAH17 CFAP74 TEKT4 MPHOSPH9 PLCE1 | 1.00e-05 | 670 | 254 | 23 | GO:0120031 |
| GeneOntologyBiologicalProcess | regulation of Schwann cell differentiation | 1.81e-05 | 5 | 254 | 3 | GO:0014038 | |
| GeneOntologyBiologicalProcess | microtubule-based process | MAK CDC20B TOGARAM1 EYA1 LYST KIF24 CHRNA7 FSIP2 ALMS1 BRCA1 BRCA2 VPS13A KIF14 MAP7D2 CHRFAM7A IQUB CFAP47 IFT22 ANK3 APC DICER1 C2CD3 DNAH17 PDE4DIP CFAP74 TEKT4 CEP295 KIF18B PHLDB2 SON | 1.88e-05 | 1058 | 254 | 30 | GO:0007017 |
| GeneOntologyBiologicalProcess | inner ear receptor cell differentiation | 2.47e-05 | 96 | 254 | 8 | GO:0060113 | |
| GeneOntologyBiologicalProcess | cell junction assembly | HIPK1 IQSEC2 MPDZ NFASC GRHL2 ZDHHC8 PTPRA PTPRD FGFR1 ANK2 PCLO PCDHB14 PCDHB11 APC GRM6 PCDHB16 THY1 PKP3 SNAI1 PHLDB2 | 2.78e-05 | 569 | 254 | 20 | GO:0034329 |
| GeneOntologyBiologicalProcess | organelle assembly | MAK TBC1D9B PDGFRB CDC20B TOGARAM1 WNK1 KIF24 ASAP1 FARP2 FSIP2 PTPRD ALMS1 BRCA1 FAM161A HPS4 PCDH15 AGFG1 FGFR1 FAM149B1 IQUB CFAP47 IFT22 ATG2B DICER1 TBC1D17 C2CD3 DNAH17 CFAP74 TEKT4 CEP295 MPHOSPH9 | 2.92e-05 | 1138 | 254 | 31 | GO:0070925 |
| GeneOntologyBiologicalProcess | positive regulation of vascular endothelial growth factor production | 4.18e-05 | 32 | 254 | 5 | GO:0010575 | |
| GeneOntologyBiologicalProcess | synapse organization | MYO5B IQSEC2 NFASC ZDHHC8 CHRNA7 ASAP1 CACNG2 PTPRD FGFR1 CHRFAM7A SHISA6 ANK3 PCLO PCDHB14 PCDHB11 LRRC4C GRM6 SEZ6L2 PTPRT PCDHB16 CAPRIN2 SEZ6L | 4.31e-05 | 685 | 254 | 22 | GO:0050808 |
| GeneOntologyBiologicalProcess | synaptic signaling | MYO5B IQSEC2 WNK1 CHRNA7 ITPR1 CACNG2 JAK2 PTPRA PTPRD VPS13A KCNN2 SYN2 PLCG1 CHRFAM7A SHISA6 PCLO ANXA7 PCDHB14 PCDHB11 RELA LRRC4C GRM6 PCDHB16 EGR2 CACNG4 EIF2AK4 EXOC4 | 7.65e-05 | 976 | 254 | 27 | GO:0099536 |
| GeneOntologyBiologicalProcess | microtubule cytoskeleton organization | CDC20B TOGARAM1 EYA1 KIF24 FSIP2 ALMS1 BRCA1 BRCA2 KIF14 MAP7D2 CFAP47 ANK3 APC DICER1 C2CD3 DNAH17 PDE4DIP CFAP74 CEP295 KIF18B PHLDB2 SON | 8.94e-05 | 720 | 254 | 22 | GO:0000226 |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 9.32e-05 | 20 | 254 | 4 | GO:0006607 | |
| GeneOntologyBiologicalProcess | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process | 9.87e-05 | 8 | 254 | 3 | GO:0015014 | |
| GeneOntologyBiologicalProcess | sensory organ development | EYA4 PDGFRB HIPK1 TPRN EYA1 ADGRV1 GRHL2 ALMS1 PCDH15 NHS PDS5A DLX2 FGFR1 USH2A FAT3 APC GRM6 DICER1 THY1 TMEM132E RORB CUX1 | 1.09e-04 | 730 | 254 | 22 | GO:0007423 |
| GeneOntologyBiologicalProcess | calcium-mediated signaling | PDGFRB CMYA5 ITPR1 ALMS1 FCGR3A C3AR1 CCR4 PLCG1 EIF2AK3 ANK2 EXOC4 PLCE1 | 1.21e-04 | 266 | 254 | 12 | GO:0019722 |
| GeneOntologyBiologicalProcess | regulation of plasma membrane bounded cell projection organization | MAK TBC1D9B MYO5B MDM2 CSMD3 KIF24 ASAP1 ITPR1 KIDINS220 PTPRD PTPRZ1 FGFR1 ESPN NDNF FAT3 APC LRRC4C TBC1D17 ARSB THY1 CAPRIN2 MPHOSPH9 CUX1 PLCE1 | 1.33e-04 | 846 | 254 | 24 | GO:0120035 |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 1.47e-04 | 9 | 254 | 3 | GO:0033133 | |
| GeneOntologyBiologicalProcess | mesenchyme morphogenesis | 1.48e-04 | 65 | 254 | 6 | GO:0072132 | |
| GeneOntologyBiologicalProcess | perforin production | 1.51e-04 | 2 | 254 | 2 | GO:0035944 | |
| GeneOntologyBiologicalProcess | positive regulation of heart rate involved in baroreceptor response to decreased systemic arterial blood pressure | 1.51e-04 | 2 | 254 | 2 | GO:0001988 | |
| GeneOntologyBiologicalProcess | regulation of myelination | 1.75e-04 | 67 | 254 | 6 | GO:0031641 | |
| GeneOntologyBiologicalProcess | regulation of cell projection organization | MAK TBC1D9B MYO5B MDM2 CSMD3 KIF24 ASAP1 ITPR1 KIDINS220 PTPRD PTPRZ1 FGFR1 ESPN NDNF FAT3 APC LRRC4C TBC1D17 ARSB THY1 CAPRIN2 MPHOSPH9 CUX1 PLCE1 | 1.80e-04 | 863 | 254 | 24 | GO:0031344 |
| GeneOntologyBiologicalProcess | sensory perception of sound | 1.80e-04 | 198 | 254 | 10 | GO:0007605 | |
| GeneOntologyBiologicalProcess | sensory perception of mechanical stimulus | SCN11A EYA4 TPRN EYA1 ADGRV1 ALMS1 PGAP1 PCDH15 FGFR1 USH2A ESPN | 1.88e-04 | 238 | 254 | 11 | GO:0050954 |
| GeneOntologyBiologicalProcess | postsynaptic signal transduction | 2.06e-04 | 69 | 254 | 6 | GO:0098926 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 2.08e-04 | 10 | 254 | 3 | GO:1903301 | |
| GeneOntologyBiologicalProcess | photoreceptor cell maintenance | 2.74e-04 | 47 | 254 | 5 | GO:0045494 | |
| GeneOntologyBiologicalProcess | inner ear receptor cell development | 2.81e-04 | 73 | 254 | 6 | GO:0060119 | |
| GeneOntologyBiologicalProcess | dendrite development | MYO5B MPDZ CSMD3 CHRNA7 ASAP1 KIDINS220 PTPRD PTPRZ1 CHRFAM7A FAT3 KLF7 CAPRIN2 CUX1 | 2.81e-04 | 335 | 254 | 13 | GO:0016358 |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 2.83e-04 | 11 | 254 | 3 | GO:0110011 | |
| GeneOntologyBiologicalProcess | regulation of nervous system process | SOX10 CHRNA7 CHRFAM7A EIF2AK3 SHISA6 PCLO DICER1 EGR2 CACNG4 | 3.30e-04 | 175 | 254 | 9 | GO:0031644 |
| GeneOntologyBiologicalProcess | protein dephosphorylation | PDGFRB LRRIQ4 EYA1 CMYA5 PTPRA PTPRD PTPRZ1 PTPRU PTPRT VCAN DUSP16 | 3.51e-04 | 256 | 254 | 11 | GO:0006470 |
| GeneOntologyBiologicalProcess | cell cycle checkpoint signaling | 3.75e-04 | 217 | 254 | 10 | GO:0000075 | |
| GeneOntologyBiologicalProcess | hair cell differentiation | 4.03e-04 | 78 | 254 | 6 | GO:0035315 | |
| GeneOntologyBiologicalProcess | response to cold | 4.41e-04 | 52 | 254 | 5 | GO:0009409 | |
| GeneOntologyBiologicalProcess | baroreceptor response to decreased systemic arterial blood pressure | 4.49e-04 | 3 | 254 | 2 | GO:0001982 | |
| GeneOntologyBiologicalProcess | transmission of nerve impulse | 4.78e-04 | 112 | 254 | 7 | GO:0019226 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 4.82e-04 | 13 | 254 | 3 | GO:0033131 | |
| GeneOntologyBiologicalProcess | neurotransmitter receptor diffusion trapping | 4.82e-04 | 13 | 254 | 3 | GO:0099628 | |
| GeneOntologyBiologicalProcess | postsynaptic neurotransmitter receptor diffusion trapping | 4.82e-04 | 13 | 254 | 3 | GO:0098970 | |
| GeneOntologyBiologicalProcess | centriole assembly | 4.82e-04 | 53 | 254 | 5 | GO:0098534 | |
| GeneOntologyBiologicalProcess | nuclear export | 4.95e-04 | 185 | 254 | 9 | GO:0051168 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | DCHS2 WNK1 PTPRD PCDH15 PCDHGA4 FAT3 PCDHB14 PCDHB11 PCDHA1 LRRC4C PTPRT PCDHB16 | 5.34e-04 | 313 | 254 | 12 | GO:0098742 |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | DCHS2 PCDH15 PCDHGA4 FAT3 PCDHB14 PCDHB11 PCDHA1 PTPRT PCDHB16 | 5.35e-04 | 187 | 254 | 9 | GO:0007156 |
| GeneOntologyBiologicalProcess | anterograde trans-synaptic signaling | MYO5B IQSEC2 WNK1 CHRNA7 CACNG2 JAK2 PTPRA PTPRD VPS13A KCNN2 SYN2 PLCG1 CHRFAM7A SHISA6 PCLO PCDHB14 PCDHB11 LRRC4C GRM6 PCDHB16 EGR2 CACNG4 EIF2AK4 EXOC4 | 5.39e-04 | 931 | 254 | 24 | GO:0098916 |
| GeneOntologyBiologicalProcess | chemical synaptic transmission | MYO5B IQSEC2 WNK1 CHRNA7 CACNG2 JAK2 PTPRA PTPRD VPS13A KCNN2 SYN2 PLCG1 CHRFAM7A SHISA6 PCLO PCDHB14 PCDHB11 LRRC4C GRM6 PCDHB16 EGR2 CACNG4 EIF2AK4 EXOC4 | 5.39e-04 | 931 | 254 | 24 | GO:0007268 |
| GeneOntologyBiologicalProcess | modulation of chemical synaptic transmission | MYO5B IQSEC2 WNK1 CHRNA7 CACNG2 JAK2 PTPRA PTPRD VPS13A KCNN2 PLCG1 CHRFAM7A SHISA6 PCLO LRRC4C GRM6 EGR2 CACNG4 EIF2AK4 | 5.96e-04 | 663 | 254 | 19 | GO:0050804 |
| GeneOntologyBiologicalProcess | regulation of trans-synaptic signaling | MYO5B IQSEC2 WNK1 CHRNA7 CACNG2 JAK2 PTPRA PTPRD VPS13A KCNN2 PLCG1 CHRFAM7A SHISA6 PCLO LRRC4C GRM6 EGR2 CACNG4 EIF2AK4 | 6.07e-04 | 664 | 254 | 19 | GO:0099177 |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 6.08e-04 | 14 | 254 | 3 | GO:1903299 | |
| GeneOntologyBiologicalProcess | receptor diffusion trapping | 6.08e-04 | 14 | 254 | 3 | GO:0098953 | |
| GeneOntologyBiologicalProcess | trans-synaptic signaling | MYO5B IQSEC2 WNK1 CHRNA7 CACNG2 JAK2 PTPRA PTPRD VPS13A KCNN2 SYN2 PLCG1 CHRFAM7A SHISA6 PCLO PCDHB14 PCDHB11 LRRC4C GRM6 PCDHB16 EGR2 CACNG4 EIF2AK4 EXOC4 | 6.08e-04 | 939 | 254 | 24 | GO:0099537 |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 4.35e-06 | 10 | 256 | 4 | GO:0044614 | |
| GeneOntologyCellularComponent | leading edge membrane | ADGRV1 CHRNA7 PTPRZ1 PLCG1 USH2A CHRFAM7A SHISA6 DOCK8 APC THY1 PLEKHA1 MTMR9 | 1.15e-05 | 210 | 256 | 12 | GO:0031256 |
| GeneOntologyCellularComponent | annulate lamellae | 2.00e-05 | 14 | 256 | 4 | GO:0005642 | |
| GeneOntologyCellularComponent | Schaffer collateral - CA1 synapse | MYO5B IQSEC2 ITPR1 CACNG2 PTPRA PTPRD SYN2 PLCG1 LRRC4C EXOC4 | 2.21e-05 | 155 | 256 | 10 | GO:0098685 |
| GeneOntologyCellularComponent | glutamatergic synapse | SCN11A MYO5B IQSEC2 MPDZ ZDHHC8 ASAP1 CACNG2 JAK2 PTPRD PTPRZ1 KCNN2 SYN2 FGFR1 PLCG1 SHISA6 PRUNE2 PCLO APC RELA LRRC4C DICER1 PTPRT THY1 CACNG4 SEZ6L | 2.62e-05 | 817 | 256 | 25 | GO:0098978 |
| GeneOntologyCellularComponent | neuron to neuron synapse | IQSEC2 MPDZ CHRNA7 ITPR1 CACNG2 PTPRD PTPRZ1 SYN2 CHRFAM7A SHISA6 ANK2 ANK3 PCLO LRRC4C DICER1 PTPRT CACNG4 EXOC4 | 8.60e-05 | 523 | 256 | 18 | GO:0098984 |
| GeneOntologyCellularComponent | asymmetric synapse | IQSEC2 MPDZ CHRNA7 ITPR1 CACNG2 PTPRZ1 SYN2 CHRFAM7A SHISA6 ANK2 ANK3 PCLO LRRC4C DICER1 PTPRT CACNG4 EXOC4 | 8.89e-05 | 477 | 256 | 17 | GO:0032279 |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 9.71e-05 | 8 | 256 | 3 | GO:1990723 | |
| GeneOntologyCellularComponent | postsynapse | MYO5B IQSEC2 MPDZ ZDHHC8 CHRNA7 ASAP1 ITPR1 CACNG2 JAK2 PTPRZ1 KCNN2 SYN2 FGFR1 CHRFAM7A SHISA6 ANK2 ANK3 PCLO APC LRRC4C GRM6 DICER1 PTPRT THY1 CACNG4 SEZ6L EXOC4 | 1.40e-04 | 1018 | 256 | 27 | GO:0098794 |
| GeneOntologyCellularComponent | cell leading edge | PDGFRB ADGRV1 CHRNA7 PTPRZ1 NHS PLCG1 USH2A CHRFAM7A SHISA6 DOCK8 APC THY1 PLEKHA1 MTMR9 PHLDB2 EXOC4 PLCE1 | 1.56e-04 | 500 | 256 | 17 | GO:0031252 |
| GeneOntologyCellularComponent | postsynaptic specialization | IQSEC2 MPDZ CHRNA7 ITPR1 CACNG2 PTPRZ1 SYN2 CHRFAM7A SHISA6 ANK2 ANK3 PCLO LRRC4C DICER1 PTPRT CACNG4 EXOC4 | 1.68e-04 | 503 | 256 | 17 | GO:0099572 |
| GeneOntologyCellularComponent | photoreceptor connecting cilium | 2.95e-04 | 48 | 256 | 5 | GO:0032391 | |
| GeneOntologyCellularComponent | photoreceptor cell cilium | 3.21e-04 | 139 | 256 | 8 | GO:0097733 | |
| GeneOntologyCellularComponent | synaptic membrane | SCN11A IQSEC2 CHRNA7 ITPR1 CACNG2 PTPRA PTPRD PTPRZ1 KCNN2 CHRFAM7A SHISA6 ANK2 ANK3 LRRC4C GRM6 PTPRT CACNG4 SEZ6L | 3.26e-04 | 583 | 256 | 18 | GO:0097060 |
| GeneOntologyCellularComponent | spine apparatus membrane | 4.45e-04 | 3 | 256 | 2 | GO:0098897 | |
| GeneOntologyCellularComponent | postsynaptic density | IQSEC2 MPDZ ITPR1 CACNG2 PTPRZ1 SYN2 SHISA6 ANK2 ANK3 PCLO LRRC4C DICER1 PTPRT CACNG4 EXOC4 | 4.77e-04 | 451 | 256 | 15 | GO:0014069 |
| GeneOntologyCellularComponent | postsynaptic membrane | IQSEC2 CHRNA7 CACNG2 PTPRZ1 KCNN2 CHRFAM7A SHISA6 ANK2 ANK3 LRRC4C GRM6 PTPRT CACNG4 SEZ6L | 5.03e-04 | 405 | 256 | 14 | GO:0045211 |
| GeneOntologyCellularComponent | neuron projection membrane | 5.12e-04 | 82 | 256 | 6 | GO:0032589 | |
| GeneOntologyCellularComponent | 9+0 non-motile cilium | 6.10e-04 | 153 | 256 | 8 | GO:0097731 | |
| GeneOntologyCellularComponent | postsynaptic specialization membrane | IQSEC2 CHRNA7 CACNG2 PTPRZ1 CHRFAM7A SHISA6 LRRC4C PTPRT CACNG4 | 8.63e-04 | 201 | 256 | 9 | GO:0099634 |
| GeneOntologyCellularComponent | USH2 complex | 8.82e-04 | 4 | 256 | 2 | GO:1990696 | |
| GeneOntologyCellularComponent | Fc-gamma receptor III complex | 8.82e-04 | 4 | 256 | 2 | GO:0033001 | |
| GeneOntologyCellularComponent | somatodendritic compartment | SCN11A MYO5B MPDZ NFASC CHRNA7 ASAP1 ITPR1 CACNG2 PTPRZ1 VPS13A AGFG1 KCNN2 CCR4 USH2A CHRFAM7A SHISA6 ANK3 FAT3 PCLO APC GRM6 SEZ6L2 DICER1 THY1 ASTN1 CACNG4 SEZ6L EXOC4 | 1.16e-03 | 1228 | 256 | 28 | GO:0036477 |
| GeneOntologyCellularComponent | site of polarized growth | SCN11A CHRNA7 PTPRZ1 CHRFAM7A PCLO APC GRM6 DICER1 THY1 EXOC4 | 1.17e-03 | 253 | 256 | 10 | GO:0030427 |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.29e-03 | 18 | 256 | 3 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear pore | 1.53e-03 | 101 | 256 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | stereocilium | 1.57e-03 | 69 | 256 | 5 | GO:0032420 | |
| GeneOntologyCellularComponent | cilium | MAK TOGARAM1 ADGRV1 NPFFR1 FSIP2 ALMS1 FAM161A GLE1 VPS13A PCDH15 FAM149B1 USH2A IQUB CFAP47 HNF1A IFT22 KIAA1549 C2CD3 VCAN DNAH17 CFAP74 TEKT4 | 1.64e-03 | 898 | 256 | 22 | GO:0005929 |
| GeneOntologyCellularComponent | tight junction | 1.65e-03 | 139 | 256 | 7 | GO:0070160 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 1.77e-03 | 20 | 256 | 3 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 2.05e-03 | 21 | 256 | 3 | GO:0106068 | |
| GeneOntologyCellularComponent | axolemma | 2.05e-03 | 21 | 256 | 3 | GO:0030673 | |
| GeneOntologyCellularComponent | stereocilia ankle link | 2.17e-03 | 6 | 256 | 2 | GO:0002141 | |
| GeneOntologyCellularComponent | stereocilia ankle link complex | 2.17e-03 | 6 | 256 | 2 | GO:0002142 | |
| GeneOntologyCellularComponent | stereocilium membrane | 2.17e-03 | 6 | 256 | 2 | GO:0060171 | |
| GeneOntologyCellularComponent | periciliary membrane compartment | 2.17e-03 | 6 | 256 | 2 | GO:1990075 | |
| GeneOntologyCellularComponent | BRCA1-C complex | 2.17e-03 | 6 | 256 | 2 | GO:0070533 | |
| GeneOntologyCellularComponent | cell cortex region | 2.21e-03 | 45 | 256 | 4 | GO:0099738 | |
| GeneOntologyCellularComponent | costamere | 2.35e-03 | 22 | 256 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | cell projection membrane | ADGRV1 CHRNA7 PTPRZ1 PLCG1 USH2A CHRFAM7A SHISA6 DOCK8 APC SLC9A3 THY1 PLEKHA1 MTMR9 | 2.66e-03 | 431 | 256 | 13 | GO:0031253 |
| GeneOntologyCellularComponent | stereocilium bundle | 2.86e-03 | 79 | 256 | 5 | GO:0032421 | |
| GeneOntologyCellularComponent | non-motile cilium | 2.95e-03 | 196 | 256 | 8 | GO:0097730 | |
| GeneOntologyCellularComponent | ciliary transition zone | 3.18e-03 | 81 | 256 | 5 | GO:0035869 | |
| GeneOntologyCellularComponent | postsynaptic density membrane | 3.27e-03 | 157 | 256 | 7 | GO:0098839 | |
| GeneOntologyCellularComponent | growth cone | 3.34e-03 | 245 | 256 | 9 | GO:0030426 | |
| GeneOntologyCellularComponent | apical junction complex | 3.39e-03 | 158 | 256 | 7 | GO:0043296 | |
| GeneOntologyCellularComponent | stereocilia coupling link | 3.98e-03 | 8 | 256 | 2 | GO:0002139 | |
| HumanPheno | Hepatic encephalopathy | 5.59e-06 | 24 | 102 | 6 | HP:0002480 | |
| HumanPheno | Acholic stools | 1.77e-05 | 9 | 102 | 4 | HP:0011985 | |
| MousePheno | abnormal synaptic transmission | SCN11A ZNF609 HIVEP1 ABCA13 IQSEC2 KDM3B EYA1 ADGRV1 CMYA5 ZDHHC8 LYST CHRNA7 TASOR2 ITPR1 CACNG2 CNTNAP5 PTPRA KIDINS220 PTPRD PTPRZ1 VPS13A KCNN2 SYN2 CHRFAM7A ANK2 FOSB PCLO GRM6 PTPRT MIPOL1 THY1 DUSP16 CACNG4 EIF2AK4 MPHOSPH9 XKR5 | 1.86e-06 | 1070 | 204 | 36 | MP:0003635 |
| MousePheno | abnormal synaptic physiology | SCN11A ZNF609 HIVEP1 ABCA13 IQSEC2 KDM3B EYA1 ADGRV1 CMYA5 ZDHHC8 LYST CHRNA7 TASOR2 ITPR1 CACNG2 CNTNAP5 PTPRA KIDINS220 PTPRD PTPRZ1 VPS13A KCNN2 SYN2 CHRFAM7A ANK2 FOSB PCLO GRM6 PTPRT MIPOL1 THY1 DUSP16 CACNG4 EIF2AK4 MPHOSPH9 XKR5 | 2.12e-06 | 1076 | 204 | 36 | MP:0021009 |
| MousePheno | abnormal CNS synaptic transmission | SCN11A ZNF609 HIVEP1 ABCA13 IQSEC2 KDM3B EYA1 ADGRV1 CMYA5 ZDHHC8 LYST CHRNA7 TASOR2 ITPR1 CACNG2 CNTNAP5 PTPRA KIDINS220 PTPRD PTPRZ1 KCNN2 SYN2 CHRFAM7A ANK2 FOSB PCLO PTPRT MIPOL1 THY1 DUSP16 CACNG4 EIF2AK4 MPHOSPH9 XKR5 | 2.14e-06 | 985 | 204 | 34 | MP:0002206 |
| MousePheno | abnormal incidence of induced tumors | ERCC6 HIPK1 LYST BRCA1 BRCA2 RGPD3 RANBP2 RGPD8 APC RALGAPA2 PTPRT IFNAR1 CHFR MTDH PLCE1 | 9.62e-06 | 269 | 204 | 15 | MP:0013151 |
| MousePheno | abnormal organ/body region tumor incidence | MDM2 JAK2 BRCA1 BRCA2 PTPRZ1 RGPD3 ATP11C RANBP2 RGPD8 RBBP8 POLE ANXA7 APC RALGAPA2 PTPRT LPO CHFR MTDH | 2.42e-05 | 401 | 204 | 18 | MP:0013152 |
| MousePheno | decreased cochlear hair cell stereocilia number | 3.23e-05 | 26 | 204 | 5 | MP:0004523 | |
| MousePheno | increased incidence of induced tumors | ERCC6 LYST BRCA1 RGPD3 RANBP2 RGPD8 APC RALGAPA2 PTPRT IFNAR1 CHFR | 4.68e-05 | 173 | 204 | 11 | MP:0002021 |
| MousePheno | abnormal tumor incidence | ERCC6 HIPK1 MDM2 LYST JAK2 BRCA1 BRCA2 PTPRZ1 RGPD3 ATP11C RANBP2 RGPD8 RBBP8 POLE ANXA7 APC RALGAPA2 PTPRT IFNAR1 LPO CHFR MTDH PLCE1 | 5.42e-05 | 635 | 204 | 23 | MP:0002019 |
| MousePheno | increased organ/body region tumor incidence | MDM2 JAK2 BRCA1 BRCA2 PTPRZ1 RGPD3 ATP11C RANBP2 RGPD8 RBBP8 POLE ANXA7 APC RALGAPA2 PTPRT LPO CHFR | 6.90e-05 | 395 | 204 | 17 | MP:0010274 |
| MousePheno | abnormal oligodendrocyte physiology | 6.98e-05 | 16 | 204 | 4 | MP:0008917 | |
| MousePheno | abnormal tumor susceptibility | ERCC6 HIPK1 MDM2 LYST JAK2 BRCA1 BRCA2 PTPRZ1 RGPD3 ATP11C RANBP2 RGPD8 RBBP8 POLE ANXA7 APC RALGAPA2 PTPRT IFNAR1 LPO CHFR MTDH PLCE1 | 7.72e-05 | 650 | 204 | 23 | MP:0002166 |
| MousePheno | neoplasm | ERCC6 HIPK1 TICAM1 MDM2 LYST JAK2 BRCA1 BRCA2 PTPRZ1 RGPD3 ATP11C RANBP2 RGPD8 RBBP8 POLE ANXA7 APC RALGAPA2 PTPRT IFNAR1 LPO CHFR DOT1L MTDH PLCE1 | 9.07e-05 | 747 | 204 | 25 | MP:0002006 |
| MousePheno | increased tumor incidence | ERCC6 MDM2 LYST JAK2 BRCA1 BRCA2 PTPRZ1 RGPD3 ATP11C RANBP2 RGPD8 RBBP8 POLE ANXA7 APC RALGAPA2 PTPRT IFNAR1 LPO CHFR | 9.81e-05 | 530 | 204 | 20 | MP:0002020 |
| MousePheno | decreased outer hair cell stereocilia number | 1.15e-04 | 18 | 204 | 4 | MP:0004529 | |
| MousePheno | increased sarcoma incidence | 1.22e-04 | 102 | 204 | 8 | MP:0002032 | |
| MousePheno | abnormal glial cell physiology | 1.22e-04 | 102 | 204 | 8 | MP:0003690 | |
| MousePheno | abnormal CNS synapse formation | 1.43e-04 | 35 | 204 | 5 | MP:0004996 | |
| MousePheno | increased carcinoma incidence | MDM2 BRCA1 BRCA2 RGPD3 ATP11C RANBP2 RGPD8 POLE ANXA7 APC LPO | 1.50e-04 | 197 | 204 | 11 | MP:0002038 |
| MousePheno | abnormal GABAergic neuron physiology | 1.62e-04 | 8 | 204 | 3 | MP:0011987 | |
| MousePheno | abnormal pillar cell morphology | 1.78e-04 | 20 | 204 | 4 | MP:0003825 | |
| MousePheno | increased malignant tumor incidence | MDM2 BRCA1 BRCA2 PTPRZ1 RGPD3 ATP11C RANBP2 RGPD8 POLE ANXA7 APC LPO | 1.89e-04 | 237 | 204 | 12 | MP:0002018 |
| MousePheno | airway basal cell hyperplasia | 2.12e-04 | 2 | 204 | 2 | MP:0011115 | |
| MousePheno | abnormal airway basal cell differentiation | 2.12e-04 | 2 | 204 | 2 | MP:0011114 | |
| MousePheno | abnormal airway basal cell morphology | 2.12e-04 | 2 | 204 | 2 | MP:0011113 | |
| MousePheno | decreased lung elastance | 2.17e-04 | 21 | 204 | 4 | MP:0011045 | |
| MousePheno | pillar cell degeneration | 2.41e-04 | 9 | 204 | 3 | MP:0004586 | |
| Domain | Ran_BP1 | 1.45e-05 | 12 | 251 | 4 | PF00638 | |
| Domain | RANBD1 | 1.45e-05 | 12 | 251 | 4 | PS50196 | |
| Domain | RanBD | 2.07e-05 | 13 | 251 | 4 | SM00160 | |
| Domain | Ran_bind_dom | 2.07e-05 | 13 | 251 | 4 | IPR000156 | |
| Domain | Cadherin_CS | 1.12e-04 | 109 | 251 | 8 | IPR020894 | |
| Domain | PTPc | 1.13e-04 | 36 | 251 | 5 | SM00194 | |
| Domain | CADHERIN_1 | 1.45e-04 | 113 | 251 | 8 | PS00232 | |
| Domain | Cadherin | 1.45e-04 | 113 | 251 | 8 | PF00028 | |
| Domain | CADHERIN_2 | 1.54e-04 | 114 | 251 | 8 | PS50268 | |
| Domain | - | 1.54e-04 | 114 | 251 | 8 | 2.60.40.60 | |
| Domain | CA | 1.63e-04 | 115 | 251 | 8 | SM00112 | |
| Domain | TYR_PHOSPHATASE_PTP | 1.67e-04 | 39 | 251 | 5 | PS50055 | |
| Domain | Cadherin-like | 1.73e-04 | 116 | 251 | 8 | IPR015919 | |
| Domain | Gonadal | 1.80e-04 | 2 | 251 | 2 | IPR010849 | |
| Domain | NHS | 1.80e-04 | 2 | 251 | 2 | PF15273 | |
| Domain | DGCR6 | 1.80e-04 | 2 | 251 | 2 | PF07324 | |
| Domain | NHS_fam | 1.80e-04 | 2 | 251 | 2 | IPR024845 | |
| Domain | Cadherin | 1.95e-04 | 118 | 251 | 8 | IPR002126 | |
| Domain | FN3 | NFASC CMYA5 PTPRD PTPRZ1 USH2A NDNF PTPRU PTPRT IFNAR1 ASTN1 | 2.08e-04 | 185 | 251 | 10 | SM00060 |
| Domain | PTPase_domain | 2.13e-04 | 41 | 251 | 5 | IPR000242 | |
| Domain | Y_phosphatase | 2.13e-04 | 41 | 251 | 5 | PF00102 | |
| Domain | Grip | 3.65e-04 | 11 | 251 | 3 | SM00755 | |
| Domain | GRIP | 3.65e-04 | 11 | 251 | 3 | PF01465 | |
| Domain | FN3 | NFASC CMYA5 PTPRD PTPRZ1 USH2A NDNF PTPRU PTPRT IFNAR1 ASTN1 | 3.73e-04 | 199 | 251 | 10 | PS50853 |
| Domain | Prot-tyrosine_phosphatase-like | 3.79e-04 | 99 | 251 | 7 | IPR029021 | |
| Domain | Tyr_Pase_AS | 4.45e-04 | 73 | 251 | 6 | IPR016130 | |
| Domain | GRIP_dom | 4.82e-04 | 12 | 251 | 3 | IPR000237 | |
| Domain | GRIP | 4.82e-04 | 12 | 251 | 3 | PS50913 | |
| Domain | ALMS_motif | 5.35e-04 | 3 | 251 | 2 | IPR029299 | |
| Domain | ALMS_motif | 5.35e-04 | 3 | 251 | 2 | PF15309 | |
| Domain | FN3_dom | NFASC CMYA5 PTPRD PTPRZ1 USH2A NDNF PTPRU PTPRT IFNAR1 ASTN1 | 5.48e-04 | 209 | 251 | 10 | IPR003961 |
| Domain | Sushi | 6.54e-04 | 52 | 251 | 5 | PF00084 | |
| Domain | - | PDGFRB NFASC CMYA5 HEPACAM PTPRD FCGR3A FCGR3B PTPRZ1 FGFR1 USH2A NDNF RELA LRRC4C PTPRU PTPRT IFNAR1 ANTXRL THY1 VCAN ASTN1 | 6.66e-04 | 663 | 251 | 20 | 2.60.40.10 |
| Domain | EGF_1 | CNTNAP5 NID1 C9 USH2A FAT3 LAMB1 MUC12 VCAN ASTN1 MUC3A MEGF10 | 6.97e-04 | 255 | 251 | 11 | PS00022 |
| Domain | CCP | 7.79e-04 | 54 | 251 | 5 | SM00032 | |
| Domain | SUSHI | 9.20e-04 | 56 | 251 | 5 | PS50923 | |
| Domain | EGF_2 | CNTNAP5 NID1 C9 FAT3 LAMB1 MUC12 CD93 VCAN ASTN1 MUC3A MEGF10 | 9.55e-04 | 265 | 251 | 11 | PS01186 |
| Domain | Sushi_SCR_CCP_dom | 9.98e-04 | 57 | 251 | 5 | IPR000436 | |
| Domain | EYA_dom | 1.06e-03 | 4 | 251 | 2 | IPR006545 | |
| Domain | Heparan_SO4_deacetylase | 1.06e-03 | 4 | 251 | 2 | IPR021930 | |
| Domain | HSNSD | 1.06e-03 | 4 | 251 | 2 | PF12062 | |
| Domain | EYA_fam | 1.06e-03 | 4 | 251 | 2 | IPR028472 | |
| Domain | TYR_PHOSPHATASE_1 | 1.06e-03 | 86 | 251 | 6 | PS00383 | |
| Domain | TYR_PHOSPHATASE_dom | 1.13e-03 | 87 | 251 | 6 | IPR000387 | |
| Domain | TYR_PHOSPHATASE_2 | 1.13e-03 | 87 | 251 | 6 | PS50056 | |
| Domain | PTPc_motif | 1.17e-03 | 59 | 251 | 5 | SM00404 | |
| Domain | Tyr_Pase_cat | 1.17e-03 | 59 | 251 | 5 | IPR003595 | |
| Domain | Ig-like_fold | PDGFRB NFASC CMYA5 HEPACAM PTPRD FCGR3A FCGR3B PTPRZ1 FGFR1 USH2A NDNF RELA LRRC4C PTPRU PTPRT IFNAR1 ANTXRL THY1 VCAN ASTN1 | 1.43e-03 | 706 | 251 | 20 | IPR013783 |
| Domain | - | 1.51e-03 | 92 | 251 | 6 | 3.90.190.10 | |
| Domain | PHOSPHOPANTETHEINE | 1.75e-03 | 5 | 251 | 2 | PS00012 | |
| Domain | Autophagy-rel_C | 1.75e-03 | 5 | 251 | 2 | IPR015412 | |
| Domain | ATG_C | 1.75e-03 | 5 | 251 | 2 | PF09333 | |
| Domain | Cadherin_2 | 1.80e-03 | 65 | 251 | 5 | PF08266 | |
| Domain | Cadherin_N | 1.80e-03 | 65 | 251 | 5 | IPR013164 | |
| Pubmed | SOX10 DCHS2 DGCR6 PDGFRB HIPK1 IQSEC2 CMYA5 MICU1 FOCAD PTPRA PTPRD HPS4 USP32 PLCG1 CNOT3 MED13 DOP1B NDST1 ANK2 ANK3 ANXA7 UBR4 APC LAMB1 AKAP8L MIPOL1 PDE4DIP ASTN1 RORB R3HDM1 ZBTB11 CABIN1 CUX1 ECE2 SEZ6L EXOC4 | 1.34e-11 | 1285 | 262 | 36 | 35914814 | |
| Pubmed | SCN11A MYO5B LYST TASOR2 CREBRF FASN BRCA1 FAM161A FAM186A RGPD3 VPS13A MAP7D2 ATP11C BOD1L1 FGFR1 METTL25 MED13 RGPD5 ESPN RANBP2 ANK2 RGPD8 RBBP8 PCDHGA4 PCLO UBR4 DTL AKAP8L MIPOL1 PDIA6 C2CD3 CAPRIN2 CFAP74 CEP295 EIF2AK4 ZBTB11 MTDH CUX1 | 2.05e-11 | 1442 | 262 | 38 | 35575683 | |
| Pubmed | ZNF609 HIVEP1 FASN ALMS1 BRCA2 ZMIZ2 RGPD3 KIF14 RANBP2 RGPD8 RBBP8 UBR4 ATG2B APC ZDBF2 AKAP8L WDCP ZBTB11 CUX1 EXOC4 | 8.01e-11 | 418 | 262 | 20 | 34709266 | |
| Pubmed | ZNF609 EYA4 MYO5B TPRN EYA1 ASAP1 ITPR1 PTPRA ZFYVE9 PTPRD PTPRZ1 VPS13A KIF14 NHS RANBP2 ANK3 KIAA1549 RELA PTPRU AKAP8L PTPRT FAM171A1 NHSL1 PDIA6 C2CD3 DUSP16 PLEKHA1 EIF2AK4 MPHOSPH9 SRRM2 MTMR9 | 1.09e-10 | 1049 | 262 | 31 | 27880917 | |
| Pubmed | ZDHHC8 KIDINS220 ALMS1 ARFGAP3 NHS FAM135A RANBP2 ANK3 APC KIAA1549 PDIA6 MEIOC PLEKHA1 R3HDM1 MTDH EXOC4 | 2.04e-10 | 263 | 262 | 16 | 34702444 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | HIVEP1 IQSEC2 KDM3B MPDZ WNK1 LYST DENND2B FSIP2 ALMS1 AGFG1 KIF14 NHS BOD1L1 DOP1B DTL APC FAM171A1 NHSL1 C2CD3 PLEKHA1 MPHOSPH9 CGNL1 R3HDM1 SRRM2 TNPO3 PHLDB2 EXOC4 | 5.27e-10 | 861 | 262 | 27 | 36931259 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | HIVEP1 HIPK1 TPRN MDM2 WNK1 ALMS1 BRCA2 AGFG1 KIF14 FAM135A CNOT3 RGPD8 RBBP8 DTL APC ZDBF2 ARNT WDCP CGNL1 DOT1L EXOC4 | 5.16e-09 | 588 | 262 | 21 | 38580884 |
| Pubmed | HIPK1 CSMD3 ASAP1 FOCAD KIDINS220 BOD1L1 TET3 DOP1B LRRC4C PCDHB16 SPHKAP PDE4DIP R3HDM1 SRRM2 SEZ6L SON PLCE1 | 1.63e-08 | 407 | 262 | 17 | 12693553 | |
| Pubmed | ZNF609 EYA4 TPRN EYA1 ALMS1 BRCA2 ZMIZ2 RBBP8 ARNT MPHOSPH9 R3HDM1 | 2.44e-08 | 152 | 262 | 11 | 38360978 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TBC1D9B SREBF1 KDM3B MBD6 WNK1 ZDHHC8 LYST FOCAD JAK2 FASN ZMIZ2 DLX2 FGFR1 PLCG1 MED13 NDST1 POLE UBR4 RALGAPA2 TBC1D17 NHSL1 C2CD3 DUSP16 KCNK5 DIP2C DOT1L CABIN1 TNPO3 | 2.57e-08 | 1105 | 262 | 28 | 35748872 |
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 2.86e-08 | 13 | 262 | 5 | 31427429 | |
| Pubmed | ZNF609 EYA4 SREBF1 KDM3B MPDZ ITPR1 FARP2 PZP POLE APC DICER1 AKAP8L TBC1D17 PDIA6 ARNT WDCP EIF2AK4 QSER1 ZBTB11 EXOC4 PLCE1 | 2.90e-08 | 650 | 262 | 21 | 38777146 | |
| Pubmed | IQSEC2 ASAP1 ITPR1 MICU1 CACNG2 ARFGAP3 RGPD3 SYN2 MAP7D2 CNOT3 SHISA6 RANBP2 ANK2 RGPD8 ANK3 PCLO UBR4 ATG2B APC ZDBF2 LRRC4C AKAP8L NHSL1 SPHKAP PDE4DIP ASTN1 MTDH | 1.75e-07 | 1139 | 262 | 27 | 36417873 | |
| Pubmed | HIVEP1 HIPK1 WNK1 ASAP1 HPS4 AGFG1 RANBP2 ANK3 ANXA7 APC LAMB1 RELA MUC12 DUSP16 MPHOSPH9 CGNL1 CUX1 | 2.08e-07 | 486 | 262 | 17 | 20936779 | |
| Pubmed | ZNF609 KDM3B MPDZ WNK1 FARP2 ALMS1 GLE1 ARFGAP3 AGFG1 KIF14 BOD1L1 RGPD8 DTL APC ZDBF2 DICER1 ARID3B CEP295 MPHOSPH9 QSER1 R3HDM1 | 2.15e-07 | 733 | 262 | 21 | 34672954 | |
| Pubmed | NF-κB regulates DNA double-strand break repair in conjunction with BRCA1-CtIP complexes. | 4.23e-07 | 3 | 262 | 3 | 21908405 | |
| Pubmed | 4.23e-07 | 3 | 262 | 3 | 23063561 | ||
| Pubmed | 4.23e-07 | 3 | 262 | 3 | 19226467 | ||
| Pubmed | 4.23e-07 | 3 | 262 | 3 | 11466700 | ||
| Pubmed | Germline mutations of DICER1 in Chinese women with BRCA1/BRCA2-negative familial breast cancer. | 4.23e-07 | 3 | 262 | 3 | 25526195 | |
| Pubmed | 4.23e-07 | 3 | 262 | 3 | 35848503 | ||
| Pubmed | 4.23e-07 | 3 | 262 | 3 | 18026875 | ||
| Pubmed | 7.03e-07 | 23 | 262 | 5 | 19235731 | ||
| Pubmed | Human variation in alcohol response is influenced by variation in neuronal signaling genes. | 7.72e-07 | 171 | 262 | 10 | 20201926 | |
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | ZNF609 NFASC ADGRV1 GRHL2 DENND2B TASOR2 MICU1 FARP2 JAK2 KIDINS220 KCNN2 BOD1L1 PLCG1 TET3 MTARC1 ESPN PRUNE2 ANK3 ANXA7 SELENON PCDHB16 MIPOL1 KLF7 PKP3 HS2ST1 DIP2C EIF2AK4 QSER1 CUX1 EXOC4 | 1.08e-06 | 1489 | 262 | 30 | 28611215 |
| Pubmed | KDM3B NFASC TOGARAM1 ADGRV1 WNK1 ALMS1 CLCN6 DOP1B PRUNE2 DICER1 DIP2C | 1.27e-06 | 225 | 262 | 11 | 12168954 | |
| Pubmed | 1.49e-06 | 12 | 262 | 4 | 12460940 | ||
| Pubmed | 1.68e-06 | 4 | 262 | 3 | 35205366 | ||
| Pubmed | 1.68e-06 | 4 | 262 | 3 | 16025117 | ||
| Pubmed | 1.68e-06 | 4 | 262 | 3 | 19707196 | ||
| Pubmed | Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism. | 1.68e-06 | 4 | 262 | 3 | 18463160 | |
| Pubmed | 1.68e-06 | 4 | 262 | 3 | 9480752 | ||
| Pubmed | 1.68e-06 | 4 | 262 | 3 | 28529954 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.79e-06 | 146 | 262 | 9 | 23892456 | |
| Pubmed | CNTNAP5 CFAP92 USH2A SHISA6 LAMB1 LRRC4C RALGAPA2 PTPRT LPO MEGF10 | 3.04e-06 | 199 | 262 | 10 | 23382691 | |
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | IQSEC2 NFASC FOCAD JAK2 VPS13A PDS5A BOD1L1 FBXO34 DOP1B CFAP47 PCLO UBR4 PCDHB14 MIPOL1 DUSP16 CEP295 ZBTB11 MEGF10 MTMR9 | 3.78e-06 | 736 | 262 | 19 | 29676528 |
| Pubmed | Glial ankyrins facilitate paranodal axoglial junction assembly. | 4.18e-06 | 5 | 262 | 3 | 25362471 | |
| Pubmed | Scaffold protein harmonin (USH1C) provides molecular links between Usher syndrome type 1 and type 2. | 4.18e-06 | 5 | 262 | 3 | 16301216 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | HIVEP1 ABCA13 TOGARAM1 F5 KIF14 ANK3 UBR4 GRM6 MIPOL1 THY1 SRRM2 PHLDB2 SON | 4.19e-06 | 361 | 262 | 13 | 26167880 |
| Pubmed | MPDZ KIDINS220 ALMS1 ARHGAP29 NHS ATG2B APC ZDBF2 DICER1 NHSL1 | 4.70e-06 | 209 | 262 | 10 | 36779422 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | EYA4 MPDZ EYA1 FASN PTPRA KIDINS220 PTPRD NID1 PLCG1 RANBP2 POLE UBR4 DTL LAMB1 PTPRU DICER1 PDIA6 PKP3 DUSP16 SRRM2 MTDH TNPO3 | 5.50e-06 | 974 | 262 | 22 | 28675297 |
| Pubmed | TBC1D9B MYO5B TOGARAM1 WNK1 FARP2 ALMS1 PDS5A FAM135A CNOT3 PRUNE2 RALGAPA2 DNAH17 DIP2C CGNL1 EXOC4 | 5.96e-06 | 493 | 262 | 15 | 15368895 | |
| Pubmed | 6.93e-06 | 17 | 262 | 4 | 29718910 | ||
| Pubmed | AirID, a novel proximity biotinylation enzyme, for analysis of protein-protein interactions. | 6.93e-06 | 17 | 262 | 4 | 32391793 | |
| Pubmed | Genetic mutations associated with cigarette smoking in pancreatic cancer. | 8.18e-06 | 63 | 262 | 6 | 19351817 | |
| Pubmed | 8.31e-06 | 6 | 262 | 3 | 31142747 | ||
| Pubmed | Structural diversity and evolution of human receptor-like protein tyrosine phosphatases. | 8.31e-06 | 6 | 262 | 3 | 2170109 | |
| Pubmed | 8.31e-06 | 6 | 262 | 3 | 38554279 | ||
| Pubmed | PALB2 is an integral component of the BRCA complex required for homologous recombination repair. | 8.31e-06 | 6 | 262 | 3 | 19369211 | |
| Pubmed | In vivo assembly of the axon initial segment in motor neurons. | 8.31e-06 | 6 | 262 | 3 | 23728480 | |
| Pubmed | MPDZ FASN KIDINS220 ARHGAP29 PDS5A BOD1L1 EIF2AK3 FAM135A RANBP2 ANK2 ANK3 ATG2B APC FAM171A1 PDIA6 PLEKHA1 MPHOSPH9 EXOC4 | 8.41e-06 | 708 | 262 | 18 | 39231216 | |
| Pubmed | MPDZ WNK1 ALMS1 KIF14 DOCK8 APC KIAA1549 AKAP8L MIPOL1 PLEKHA1 CEP295 MPHOSPH9 R3HDM1 PHLDB2 | 8.60e-06 | 446 | 262 | 14 | 24255178 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | ASAP1 ALMS1 BRCA2 ARFGAP3 ARHGAP29 KIF14 MAP7D2 RANBP2 IFT22 APC RELA MIPOL1 C2CD3 MEIOC WDCP CEP295 MPHOSPH9 CGNL1 MTMR9 EXOC4 | 8.68e-06 | 853 | 262 | 20 | 28718761 |
| Pubmed | 1.05e-05 | 99 | 262 | 7 | 19730683 | ||
| Pubmed | ZNF609 BOD1L1 MAGEC1 MAGEC2 CNOT3 UBR4 ZDBF2 ARID3B QSER1 TNPO3 CUX1 | 1.10e-05 | 282 | 262 | 11 | 23667531 | |
| Pubmed | HIVEP1 ERCC6 HIPK1 TPRN KDM3B DENND2B ZFYVE9 NID1 ANK3 DOCK8 UBR4 ARNT PDE4DIP ZBTB11 TNPO3 SON | 1.25e-05 | 591 | 262 | 16 | 15231748 | |
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 9037092 | ||
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 20058854 | ||
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 21205196 | ||
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 24403063 | ||
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 23536549 | ||
| Pubmed | Identification of novel cadherins expressed in human melanoma cells. | 1.45e-05 | 7 | 262 | 3 | 9182820 | |
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 12191015 | ||
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 22821000 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 1.45e-05 | 7 | 262 | 3 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 1.45e-05 | 7 | 262 | 3 | 11353387 | |
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 30944974 | ||
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 1.45e-05 | 7 | 262 | 3 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 1.45e-05 | 7 | 262 | 3 | 17372272 | |
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 38657106 | ||
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 18949001 | ||
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 25187515 | ||
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 8603673 | ||
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 26632511 | ||
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 23818861 | ||
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 24752302 | ||
| Pubmed | 1.45e-05 | 7 | 262 | 3 | 20682751 | ||
| Pubmed | IQSEC2 MPDZ NFASC CACNG2 CNTNAP5 PTPRD RGPD3 RANBP2 ANK2 RGPD8 ANK3 UBR4 APC FAM171A1 SPHKAP PDE4DIP QSER1 CABIN1 CUX1 PHLDB2 LRRC15 | 1.53e-05 | 963 | 262 | 21 | 28671696 | |
| Pubmed | Interaction network of human early embryonic transcription factors. | ZNF609 EYA4 HIVEP1 MBD6 ALMS1 ZMIZ2 RANBP2 DTL AKAP8L ARNT EGR2 QSER1 | 1.65e-05 | 351 | 262 | 12 | 38297188 |
| Pubmed | Exome sequencing reveals pathogenic mutations in 91 strains of mice with Mendelian disorders. | 1.78e-05 | 72 | 262 | 6 | 25917818 | |
| Pubmed | 2.04e-05 | 197 | 262 | 9 | 36604605 | ||
| Pubmed | 2.30e-05 | 8 | 262 | 3 | 24067353 | ||
| Pubmed | RNF168-mediated localization of BARD1 recruits the BRCA1-PALB2 complex to DNA damage. | 2.30e-05 | 8 | 262 | 3 | 34408138 | |
| Pubmed | Toll-Like Receptors Induce Signal-Specific Reprogramming of the Macrophage Lipidome. | 2.30e-05 | 8 | 262 | 3 | 32516576 | |
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 2.30e-05 | 8 | 262 | 3 | 21670213 | |
| Pubmed | Microarray-based mutation analysis of 183 Spanish families with Usher syndrome. | 2.30e-05 | 8 | 262 | 3 | 19683999 | |
| Pubmed | Nicotinic receptor Alpha7 expression during tooth morphogenesis reveals functional pleiotropy. | 2.30e-05 | 8 | 262 | 3 | 22666322 | |
| Pubmed | 2.30e-05 | 8 | 262 | 3 | 18563556 | ||
| Pubmed | CSB interacts with BRCA1 in late S/G2 to promote MRN- and CtIP-mediated DNA end resection. | 2.30e-05 | 8 | 262 | 3 | 31501894 | |
| Pubmed | 2.30e-05 | 8 | 262 | 3 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 2.30e-05 | 8 | 262 | 3 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 2.30e-05 | 8 | 262 | 3 | 22262462 | |
| Pubmed | TFEB induces mitochondrial itaconate synthesis to suppress bacterial growth in macrophages. | 2.30e-05 | 8 | 262 | 3 | 35864246 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 2.30e-05 | 8 | 262 | 3 | 28745977 | |
| Pubmed | EYA4 ERCC6 WNK1 FASN NHS RANBP2 DTL APC PDIA6 PKP3 SRRM2 PHLDB2 SON EXOC4 | 3.25e-05 | 503 | 262 | 14 | 16964243 | |
| Pubmed | LYST ITPR1 KIDINS220 ZFYVE9 GLE1 USP32 VPS13A EIF2AK3 FAM135A DOP1B ATG2B FAM171A1 PLEKHA1 MTDH | 3.32e-05 | 504 | 262 | 14 | 34432599 | |
| Pubmed | Stabilization of mutant BRCA1 protein confers PARP inhibitor and platinum resistance. | 3.43e-05 | 9 | 262 | 3 | 24085845 | |
| Pubmed | 3.43e-05 | 9 | 262 | 3 | 28100513 | ||
| Pubmed | 3.43e-05 | 9 | 262 | 3 | 17887960 | ||
| Interaction | CFAP184 interactions | IQSEC2 FARP2 ALMS1 BRCA2 GLE1 ARFGAP3 RGPD5 ANK3 ATG2B CEP295 MPHOSPH9 | 7.13e-06 | 162 | 255 | 11 | int:CFAP184 |
| Interaction | PHF21A interactions | HIVEP1 ALMS1 BRCA2 ZMIZ2 KIF14 RANBP2 RBBP8 UBR4 ATG2B APC ZDBF2 AKAP8L EGR2 WDCP ZBTB11 EXOC4 | 8.38e-06 | 343 | 255 | 16 | int:PHF21A |
| Interaction | DUSP16 interactions | TASOR2 ALMS1 BRCA2 GLE1 ARFGAP3 RGPD5 POLE ATG2B AKAP8L MEIOC DUSP16 CEP295 EIF2AK4 | 1.09e-05 | 237 | 255 | 13 | int:DUSP16 |
| Interaction | MLF1 interactions | 1.37e-05 | 113 | 255 | 9 | int:MLF1 | |
| Interaction | EYA4 interactions | ZNF609 EYA4 ERCC6 TPRN EYA1 ALMS1 BRCA2 ZMIZ2 RBBP8 ARNT MPHOSPH9 QSER1 R3HDM1 | 1.42e-05 | 243 | 255 | 13 | int:EYA4 |
| Interaction | RNF43 interactions | ZDHHC8 KIDINS220 ALMS1 ARFGAP3 NHS FAM135A RANBP2 ANK3 APC KIAA1549 AKAP8L PDIA6 MEIOC PLEKHA1 R3HDM1 MTDH EXOC4 | 3.38e-05 | 427 | 255 | 17 | int:RNF43 |
| Interaction | EGLN3 interactions | EYA4 KDM3B MDM2 FARP2 FASN KIDINS220 ZFYVE9 BRCA1 BRCA2 ARFGAP3 KIF14 MAP7D2 ECI2 TET3 FAM135A CNOT3 RANBP2 IFT22 POLE UBR4 ATG2B APC RELA DICER1 AKAP8L PARS2 FAM171A1 NHSL1 ARNT WDCP CEP295 MPHOSPH9 R3HDM1 EXOC4 | 4.34e-05 | 1296 | 255 | 34 | int:EGLN3 |
| Interaction | YWHAG interactions | HIVEP1 IQSEC2 KDM3B MPDZ WNK1 LYST DENND2B FARP2 JAK2 ALMS1 ARHGAP29 AGFG1 SYN2 KIF14 NHS BOD1L1 HNF1A DTL APC FAM171A1 NHSL1 C2CD3 DUSP16 PLEKHA1 FAM124A MPHOSPH9 CGNL1 R3HDM1 SRRM2 TNPO3 PHLDB2 SON EXOC4 | 4.88e-05 | 1248 | 255 | 33 | int:YWHAG |
| Interaction | MST1R interactions | CCDC168 WNK1 JAK2 GLE1 BOD1L1 FGFR1 PLCG1 PCLO RELA DOT1L MTDH | 5.08e-05 | 200 | 255 | 11 | int:MST1R |
| Interaction | SYNE3 interactions | TOGARAM1 KIDINS220 ALMS1 BRCA2 ARFGAP3 ARHGAP29 KIF14 EIF2AK3 RANBP2 APC LAMB1 PDIA6 C2CD3 WDCP CEP295 MPHOSPH9 CGNL1 | 5.49e-05 | 444 | 255 | 17 | int:SYNE3 |
| Cytoband | 5q31 | 5.46e-05 | 115 | 262 | 6 | 5q31 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 1.75e-06 | 21 | 182 | 5 | 813 | |
| GeneFamily | Fibronectin type III domain containing | 2.20e-04 | 160 | 182 | 8 | 555 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.68e-04 | 57 | 182 | 5 | 1179 | |
| GeneFamily | Clustered protocadherins | 4.61e-04 | 64 | 182 | 5 | 20 | |
| GeneFamily | Fibronectin type III domain containing|USH2 complex | 5.97e-04 | 4 | 182 | 2 | 1244 | |
| GeneFamily | EYA transcriptional coactivator and phosphatases | 5.97e-04 | 4 | 182 | 2 | 1044 | |
| GeneFamily | Cadherin related | 6.15e-04 | 17 | 182 | 3 | 24 | |
| GeneFamily | Ring finger proteins|Fanconi anemia complementation groups|Protein phosphatase 1 regulatory subunits|BRCA1 A complex|BRCA1 B complex|BRCA1 C complex | 9.88e-04 | 5 | 182 | 2 | 1336 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 2.05e-03 | 7 | 182 | 2 | 917 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | HIVEP1 KDM3B TOGARAM1 DENND2B ITPR1 PTPRA KIDINS220 ZFYVE9 BRCA1 BRCA2 VPS13A ARHGAP29 AGFG1 KIF14 PDS5A MED13 DOP1B RANBP2 APC DICER1 FAM171A1 C2CD3 KLF7 MPHOSPH9 R3HDM1 ZBTB11 CUX1 SON PLCE1 | 9.51e-09 | 856 | 260 | 29 | M4500 |
| Coexpression | LAKE_ADULT_KIDNEY_C3_PROXIMAL_TUBULE_EPITHELIAL_CELLS_S1_S2 | PTPRD VPS13A PCDH15 NHS PRUNE2 ANK2 ANK3 PCLO DIP2C CGNL1 SRRM2 CUX1 EXOC4 | 3.60e-07 | 221 | 260 | 13 | M39222 |
| Coexpression | SENGUPTA_NASOPHARYNGEAL_CARCINOMA_UP | HIVEP1 ASAP1 FCGR3B PGAP1 NID1 ATP11C RBBP8 DTL LAMB1 PIWIL4 THY1 VCAN MPHOSPH9 QSER1 KIF18B | 4.55e-07 | 305 | 260 | 15 | M19875 |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HGABA | NFASC CSMD3 LYST CACNG2 NDST3 CREBRF FSIP2 PGAP1 SYN2 MAP7D2 BOD1L1 DOP1B ANK2 ANK3 PCLO APC KIAA1549 SEZ6L2 DICER1 PTPRT KLF7 VCAN PDE4DIP CAPRIN2 PLEKHA1 CACNG4 R3HDM1 SEZ6L | 5.88e-06 | 1106 | 260 | 28 | M39071 |
| Coexpression | DESCARTES_FETAL_THYMUS_THYMIC_EPITHELIAL_CELLS | EYA4 MYO5B EYA1 CMYA5 MAP7D2 NHS ANK3 KIAA1549 LRRC4C PTPRT CGNL1 SEZ6L | 6.52e-06 | 244 | 260 | 12 | M40312 |
| Coexpression | DESCARTES_FETAL_PLACENTA_VASCULAR_ENDOTHELIAL_CELLS | 8.26e-06 | 102 | 260 | 8 | M40283 | |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | HIVEP1 HIPK1 CREBRF PDS5A BOD1L1 FGFR1 OSGIN2 EIF2AK3 MED13 RGPD5 RANBP2 ZNF211 RGPD8 RELA ZDBF2 RALGAPA2 DICER1 ARID3B ZBTB11 SON | 1.68e-05 | 680 | 260 | 20 | M41089 |
| Coexpression | GSE17301_CTRL_VS_48H_ACD3_ACD28_IFNA5_STIM_CD8_TCELL_DN | PTPRA EIF2AK3 NDNF PARS2 TBC1D17 CD93 CAPRIN2 PLEKHA1 MPHOSPH9 XKR5 | 3.35e-05 | 200 | 260 | 10 | M8048 |
| Coexpression | GSE2770_TGFB_AND_IL4_VS_TGFB_AND_IL12_TREATED_ACT_CD4_TCELL_6H_DN | KIDINS220 ATP11C ECI2 ARID3B C2CD3 EGR2 HS2ST1 R3HDM1 SON EXOC4 | 3.35e-05 | 200 | 260 | 10 | M6102 |
| Coexpression | GSE7509_UNSTIM_VS_FCGRIIB_STIM_MONOCYTE_DN | 4.43e-05 | 166 | 260 | 9 | M6826 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_1000 | ERCC6 LYST KIF24 TASOR2 ZFYVE9 ALMS1 BRCA1 BRCA2 PGAP1 USP32 VPS13A KIF14 MAP7D2 ATP11C OSGIN2 METTL25 FAM135A RBBP8 POLE RALGAPA2 ARID3B MEIOC LACC1 CAPRIN2 PLEKHA1 CEP295 RNF212B | 2.25e-06 | 820 | 255 | 27 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_k-means-cluster#5_top-relative-expression-ranked_500 | 4.40e-06 | 78 | 255 | 8 | gudmap_developingKidney_e15.5_Cap mesenchyme_500_k5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_500 | EYA4 EYA1 ATP11C FGFR1 OSGIN2 MED13 ANK3 FOSB FAT3 APC KIAA1549 C2CD3 EGR2 WDCP VCAN MEGF10 CUX1 | 7.81e-06 | 401 | 255 | 17 | gudmap_developingKidney_e15.5_Cap mesenchyme_500 |
| CoexpressionAtlas | alpha beta T cells, preT.DN2.Th, Lin-/lo CD25hi CD44+ cKit+, Thymus, avg-3 | 8.40e-06 | 85 | 255 | 8 | GSM791136_100 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000 | EYA4 PDGFRB WNK1 ASAP1 MED13 NDST1 ANK3 FAT3 APC CD93 C2CD3 WDCP VCAN MTDH CUX1 SON | 1.85e-05 | 385 | 255 | 16 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_top-relative-expression-ranked_1000_k-means-cluster#2 | MYO5B ALMS1 BRCA1 PTPRZ1 VPS13A MAP7D2 RANBP2 FAT3 PCLO ZDBF2 DUSP16 ASTN1 CACNG4 CUX1 | 4.64e-05 | 328 | 255 | 14 | Facebase_RNAseq_e10.5_Neural Epithelium Overlying Lateral Eminence_1000_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Maxillary Arch_top-relative-expression-ranked_1000_k-means-cluster#2 | 4.79e-05 | 173 | 255 | 10 | Facebase_RNAseq_e10.5_Maxillary Arch_1000_K2 | |
| CoexpressionAtlas | alpha beta T cells, preT.DN2-3.Th, Lin-/lo CD25hi CD44Int, Thymus, avg-2 | 6.33e-05 | 83 | 255 | 7 | GSM791134_100 | |
| CoexpressionAtlas | FacebaseRNAseq_e10.5_Neural Epithelium Flanking Eminence_top-relative-expression-ranked_2500_k-means-cluster#5 | HIPK1 ALMS1 BRCA1 BRCA2 PTPRZ1 PGAP1 VPS13A MAP7D2 PDS5A BOD1L1 FAM149B1 EIF2AK3 FBXO34 RANBP2 FAT3 PCLO ZDBF2 IFNAR1 ASTN1 CEP295 CACNG4 MPHOSPH9 CUX1 EXOC4 | 6.95e-05 | 831 | 255 | 24 | Facebase_RNAseq_e10.5_Neural Epithelium Flanking Eminence_2500_K5 |
| CoexpressionAtlas | B cells, proB.FrA.BM, CD19- IgM- CD43+ CD24intermediate CD45R+ AA4.1+ CD, Bone marrow, avg-2 | PDGFRB EYA1 ITPR1 BRCA1 BRCA2 KIF14 ADGRG3 POLE RUBCNL DTL SLC43A3 C1orf162 CD93 KIF18B CUX1 | 7.66e-05 | 388 | 255 | 15 | GSM538352_500 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_500 | 8.16e-05 | 149 | 255 | 9 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_500_k5 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#2_top-relative-expression-ranked_1000 | EYA4 PDGFRB ATP11C C3AR1 FAM135A MED13 ANK3 FAT3 APC C2CD3 WDCP VCAN CUX1 | 1.10e-04 | 312 | 255 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k2 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k-means-cluster#3_top-relative-expression-ranked_1000 | 1.14e-04 | 91 | 255 | 7 | DevelopingKidney_e15.5_Endothelial cells_emap-29977_k3_1000 | |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 | EYA4 KIF24 CHRNA7 FASN ALMS1 BRCA1 BRCA2 PTPRZ1 VPS13A PDS5A ATP11C BOD1L1 FAM149B1 ANK2 RBBP8 POLE DTL APC KIAA1549 ZDBF2 DICER1 ARID3B ASTN1 CFAP74 CEP295 CACNG4 QSER1 R3HDM1 MTDH XKR5 CUX1 | 1.16e-04 | 1257 | 255 | 31 | facebase_RNAseq_e10.5_Emin_LatNas_2500_K3 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000 | EYA4 PDGFRB EYA1 WNK1 ASAP1 PTPRZ1 MED13 NDST1 ANK2 ANK3 FAT3 APC LAMB1 SEZ6L2 CD93 C2CD3 WDCP VCAN ASTN1 MTDH MEGF10 CUX1 SON | 1.47e-04 | 818 | 255 | 23 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000 | EYA4 EYA1 VPS13A ATP11C C3AR1 FAM135A MED13 ANK3 FAT3 APC C2CD3 WDCP VCAN CUX1 | 1.61e-04 | 369 | 255 | 14 | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Cap mesenchyme_emap-27738_top-relative-expression-ranked_1000 | EYA4 EYA1 ADGRV1 ATP11C FGFR1 OSGIN2 MED13 ANK3 FOSB POLE FAT3 APC KIAA1549 MIPOL1 C2CD3 EGR2 WDCP VCAN CEP295 MPHOSPH9 MEGF10 CUX1 | 1.93e-04 | 779 | 255 | 22 | gudmap_developingKidney_e15.5_Cap mesenchyme_1000 |
| CoexpressionAtlas | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 | EYA4 KIF24 CHRNA7 FASN ALMS1 BRCA1 CLCN6 BRCA2 PTPRZ1 PGAP1 VPS13A KIF14 ATP11C BOD1L1 ANK2 FAT3 APC KIAA1549 ZDBF2 WDCP CAPRIN2 ASTN1 CFAP74 CEP295 QSER1 R3HDM1 XKR5 | 1.96e-04 | 1060 | 255 | 27 | facebase_RNAseq_e10.5_Emin_MedNas_2500_K1 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_100 | 2.11e-04 | 25 | 255 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_100 | |
| CoexpressionAtlas | dev gonad_e13.5_F_MeioticGermCell_Oct_top-relative-expression-ranked_500 | TASOR2 ALMS1 BRCA1 BRCA2 PGAP1 VPS13A KIF14 MAP7D2 METTL25 POLE MEIOC CAPRIN2 PLEKHA1 RNF212B | 2.49e-04 | 385 | 255 | 14 | gudmap_dev gonad_e13.5_F_MeioticGermCell_Oct_500 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | ERCC6 MYO5B KIF24 ALMS1 BRCA1 BRCA2 KIF14 MAP7D2 PDS5A ATP11C NDNF RANBP2 RBBP8 POLE PCLO ZDBF2 MPHOSPH9 | 2.57e-04 | 532 | 255 | 17 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | ADGRV1 CSMD3 KIF24 FAM186A AGFG1 USH2A TET3 PCLO CD93 VCAN ASTN1 RORB | 1.20e-09 | 186 | 262 | 12 | 23b8d51d20b05795a73892d3e20e0f9b6a207820 |
| ToppCell | NS-moderate-d_16-33-Epithelial-FOXN4+|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | MAK CDC20B KIF24 ALMS1 BRCA1 BRCA2 FAM161A DTL KIAA1549 MUC12 CEP295 PLCE1 | 1.53e-09 | 190 | 262 | 12 | 250ca4a605c1cccd77d23383e4fe6f91cf3609ba |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MYO5B CMYA5 PTPRD ARHGAP29 NHS FAM135A PRUNE2 ANK3 LAMB1 DIP2C PLEKHA1 CGNL1 | 1.94e-09 | 194 | 262 | 12 | 7002937e8903e037332a215d00fbc7c7843b33f2 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | SOX10 CMYA5 CSMD3 CNTNAP5 PCDH15 FGFR1 LRRC4C PTPRT VCAN ASTN1 CACNG4 SEZ6L | 2.59e-09 | 199 | 262 | 12 | 19a97e27a4758e794ce7246d295e112b47931a48 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | SOX10 CSMD3 CNTNAP5 PCDH15 FGFR1 LRRC4C PTPRT THY1 VCAN ASTN1 CACNG4 SEZ6L | 2.59e-09 | 199 | 262 | 12 | e60ecbb8fa7bcd3e2ce7d78f6efb2cfd1fd77698 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | SOX10 CSMD3 CNTNAP5 PCDH15 FGFR1 LRRC4C PTPRT THY1 VCAN ASTN1 CACNG4 SEZ6L | 2.59e-09 | 199 | 262 | 12 | 333056c2abe9724efeab542c0365fcfe4eff8f18 |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Glial-Neuronal-OPC-OPC-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | SOX10 CSMD3 CNTNAP5 PCDH15 FGFR1 PCDHA1 LRRC4C THY1 VCAN ASTN1 CACNG4 SEZ6L | 2.74e-09 | 200 | 262 | 12 | ad777683adeb2ce45ade570386235e311fa7ea2d |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CHRNA7 PTPRZ1 NID1 ATP11C CHRFAM7A SHISA6 NDNF LACC1 SPHKAP ECE2 SEZ6L | 1.65e-08 | 188 | 262 | 11 | ee572246e0c2f41bdbc29a03edc67b831af95c09 |
| ToppCell | moderate-Epithelial-FOXN4+|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | ABCA13 CDC20B MDM2 KIF24 ALMS1 BRCA2 FAM161A DTL MUC12 CEP295 PLCE1 | 2.28e-08 | 194 | 262 | 11 | 5dffa578149104dda33774361e9e77b227b5f1ce |
| ToppCell | moderate-Epithelial-FOXN4+|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | CDC20B MDM2 KIF24 ALMS1 BRCA1 BRCA2 FAM161A DTL MUC12 CEP295 PLCE1 | 2.28e-08 | 194 | 262 | 11 | dff3fb10372053951d41e0ccd41aac3ece6009bd |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | ABCA13 ADGRV1 GRHL2 F5 PTPRD FCGR3B ADGRG3 FAT3 GRM6 PTPRT MUC3A | 2.40e-08 | 195 | 262 | 11 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | ABCA13 ADGRV1 GRHL2 F5 PTPRD FCGR3B ADGRG3 FAT3 GRM6 PTPRT MUC3A | 2.40e-08 | 195 | 262 | 11 | d3755929ebbbf5e3afde44281e9056ddb614a291 |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | CDC20B KIF24 ALMS1 BRCA2 FAM161A CFAP47 DTL CEP295 CACNG4 PLCE1 | 3.34e-08 | 157 | 262 | 10 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | ABCA13 ADGRV1 CSMD3 F5 CNTNAP5 PCDH15 USH2A POLE FAT3 MEGF10 | 4.49e-08 | 162 | 262 | 10 | bf886e22ff2a20353499004b53f25fb9e6574896 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | NDST3 PTPRD FAT3 KIAA1549 LAMB1 KCNV1 RORB R3HDM1 LYPD8 PHLDB2 | 1.34e-07 | 182 | 262 | 10 | 14a117c5e50db31ee1b2cf4df4d133451fd6d55f |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 ADGRV1 CSMD3 PTPRD PCDH15 USH2A FAT3 PCLO LRRC4C PLCE1 | 1.49e-07 | 184 | 262 | 10 | 2cbed6462fea2622871bb7e49b0df3d984239281 |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 ADGRV1 CSMD3 PTPRD PCDH15 USH2A FAT3 PCLO LRRC4C PLCE1 | 1.49e-07 | 184 | 262 | 10 | 2b19a8c5f823e00812908b23e66bb4e563278aff |
| ToppCell | facs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ABCA13 ADGRV1 CSMD3 PTPRD PCDH15 USH2A FAT3 PCLO LRRC4C PLCE1 | 1.49e-07 | 184 | 262 | 10 | ea7a7e2bac46d4d2c31a5d576b38a032b5335062 |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | EYA1 CHRNA7 NHS ATP11C CHRFAM7A SHISA6 NDNF LACC1 ECE2 SEZ6L | 1.56e-07 | 185 | 262 | 10 | 79cff4f3c6ae8e5ea60e8eae082b9275f2679ee9 |
| ToppCell | renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | PTPRD PCDH15 SYN2 NHS PRUNE2 THY1 KCNK5 FAM124A CGNL1 RNF212B | 1.73e-07 | 187 | 262 | 10 | 3ae3b8de1a195d4d5057cf3c64fcdb5f48681ce5 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Intermediate_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | ABCA13 ADGRV1 ARHGAP29 NHS FGFR1 PRUNE2 RBBP8 LAMB1 DIP2C PLEKHA1 | 1.82e-07 | 188 | 262 | 10 | af740fa78542438fdff627ea1f74f4eee43316be |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | PDGFRB PTPRD PGAP1 FGFR1 EIF2AK3 RANBP2 LAMB1 ZDBF2 VCAN PHLDB2 | 1.91e-07 | 189 | 262 | 10 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 1.91e-07 | 189 | 262 | 10 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_distal_convoluted_tubule_epithelial_cell_cycling-Cycling_Distal_Convoluted_Tubule_Cell_low-phase|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.93e-07 | 144 | 262 | 9 | f6061dd965a2b2fe6ad864f8aecc06d2e74881ce | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 2.00e-07 | 190 | 262 | 10 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | DGCR6 CDC20B KIF24 BRCA1 BRCA2 FAM161A IFT22 MUC12 CEP295 PLCE1 | 2.00e-07 | 190 | 262 | 10 | 0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | EYA4 CNTNAP5 PTPRD PTPRZ1 LRRC4C PTPRT TMEM132E SPHKAP RORB CUX1 | 2.00e-07 | 190 | 262 | 10 | 1bbbf0ce222e51f9fd2daca0c18d3965fd4efd31 |
| ToppCell | 3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | DGCR6 CDC20B KIF24 BRCA1 BRCA2 FAM161A IFT22 MUC12 CEP295 PLCE1 | 2.00e-07 | 190 | 262 | 10 | 05455775845f4ded5c27e7b83242078d23162aaf |
| ToppCell | NS-moderate-d_0-4|moderate / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | ABCA13 ADGRV1 DENND2B PTPRZ1 FAM161A PZP IQUB CFAP47 ANK3 CFAP74 | 2.32e-07 | 193 | 262 | 10 | ea345d34440b25f65358a53dc72831998d1c3620 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | MYO5B GRHL2 NHS ANK3 RBBP8 PCLO LAMB1 FAM171A1 PLEKHA1 CGNL1 | 2.55e-07 | 195 | 262 | 10 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 |
| ToppCell | Fibroblasts-DKK3+_Fibroblasts|Fibroblasts / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | PDGFRB F5 PTPRD PTPRZ1 PRUNE2 NHSL1 HSD3B7 THY1 TM4SF1 LRRC15 | 2.67e-07 | 196 | 262 | 10 | 24d64b67aa9b0e8215ad06f9101c1314b3483620 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SREBF1 NFASC HEPACAM FASN PTPRA PTPRD ANK2 SEZ6L2 RORB MEGF10 | 2.67e-07 | 196 | 262 | 10 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-Activated_MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 3.07e-07 | 199 | 262 | 10 | 8b86c69aaf60feff53aa782559cfece7342a23de | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 3.07e-07 | 199 | 262 | 10 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 3.07e-07 | 199 | 262 | 10 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1--L3-4|Neuronal / cells hierarchy compared to all cells using T-Statistic | CCDC168 CNTNAP5 BRCA2 PTPRZ1 RUBCNL LRRC4C PTPRT SPHKAP RORB PHLDB2 | 3.22e-07 | 200 | 262 | 10 | 47791c93d03ee17c1ce17e27f075be4fc6f2590e |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1|Neuronal / cells hierarchy compared to all cells using T-Statistic | CCDC168 CNTNAP5 BRCA2 PTPRZ1 RUBCNL LRRC4C PTPRT SPHKAP RORB PHLDB2 | 3.22e-07 | 200 | 262 | 10 | f75d95376a340d467c4392b872b2a2dbdd184556 |
| ToppCell | Neuronal-Excitatory-eC(RORB)-eC_1-CARM1P1-|Neuronal / cells hierarchy compared to all cells using T-Statistic | CCDC168 CNTNAP5 BRCA2 PTPRZ1 RUBCNL LRRC4C PTPRT SPHKAP RORB PHLDB2 | 3.22e-07 | 200 | 262 | 10 | fae26560ba3b0b638b6bcf92f05330824b31d21b |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-4|TCGA-Lung / Sample_Type by Project: Shred V9 | 7.09e-07 | 168 | 262 | 9 | aefea14b8b1c1b6a05f827effd22ba15274fddc9 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | CCDC168 CNTNAP5 BRCA2 RUBCNL LRRC4C PTPRT SPHKAP RORB PHLDB2 | 9.06e-07 | 173 | 262 | 9 | 8ac2e9d39c0f76e674f8bd59d1da246bab4867c8 |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_4|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 9.97e-07 | 175 | 262 | 9 | 06af6629766e2054e6995e8cdb3907658fec49d3 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Ptprt_Pkp2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 1.04e-06 | 176 | 262 | 9 | 05ec715439f2eb1696f5d8855da0dd1dd70effd0 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_PRSS12|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.10e-06 | 177 | 262 | 9 | f902600c639087664316b3cf30cab243bc3d1c5c | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6-Inh_L1_PAX6_CA4|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-06 | 178 | 262 | 9 | e86ed30652c2de70f16430f04b78789b87df4af2 | |
| ToppCell | Anterior_Cingulate_gyrus_(CgG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Anterior_Cingulate_gyrus_(CgG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.15e-06 | 178 | 262 | 9 | 0e1bedf991189d0ef9b40dac9281bdf4739333a1 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-06 | 179 | 262 | 9 | d15182c668d7c37be8214cad9f1fe35d1409c9a1 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.20e-06 | 179 | 262 | 9 | 8766a5a066091879f521acfc612abf563ff78808 | |
| ToppCell | 5'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.20e-06 | 179 | 262 | 9 | e22a275a7c0ed19113c833a75d6c49fcc19aa13a | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-06 | 180 | 262 | 9 | da723df348d7b8449bb1124f23fe6fa706412adb | |
| ToppCell | droplet-Heart-nan-3m-Neuronal-cardiac_neuron|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-06 | 180 | 262 | 9 | 50758b1e7be2e43f83c10ab106900c067e61f5f7 | |
| ToppCell | droplet-Heart-nan-3m-Neuronal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.26e-06 | 180 | 262 | 9 | 5b146a94708b3c3610542a4d0925f3f7a2b19185 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.32e-06 | 181 | 262 | 9 | 1037051eb82313c13346617b33f3c4c648181c4d | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ASAP1 ALMS1 ARHGAP29 PCDHB14 PCDHB11 SLC43A3 FAM171A1 FAM124A TM4SF1 | 1.32e-06 | 181 | 262 | 9 | 4df7972f88117108698efd06b124b232f8588981 |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 181 | 262 | 9 | 9542c19edc9bd2cba68c01c2a8407705398e3011 | |
| ToppCell | 18-Airway-Epithelial-Submucosal_gland_basal|Airway / Age, Tissue, Lineage and Cell class | 1.32e-06 | 181 | 262 | 9 | 33938e6521712058312879f84f4ae381c2bfc379 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Proximal_tubule_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.32e-06 | 181 | 262 | 9 | 8f04f8cac5d705dc5f6cf6f4516d6e45b0aa4ae5 | |
| ToppCell | droplet-Liver-hepatocytes-3m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ASAP1 ALMS1 ARHGAP29 PCDHB14 PCDHB11 SLC43A3 FAM171A1 FAM124A TM4SF1 | 1.32e-06 | 181 | 262 | 9 | cbb530566893281289026bfd93adf721decd4ca3 |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial-LEC6_(ADAMTS4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ASAP1 ARHGAP29 NDNF ADGRG3 SLC43A3 RALGAPA2 BCL6B TM4SF1 PHLDB2 | 1.38e-06 | 182 | 262 | 9 | fd786c88826ad3d5cc5c3d80f8e392d6be1b5267 |
| ToppCell | wk_15-18-Epithelial-PNS-SST+_neuron|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | CACNG2 CNTNAP5 MAP7D2 DLX2 CHRFAM7A PRUNE2 TMEM132E ECE2 SEZ6L | 1.38e-06 | 182 | 262 | 9 | a7e77aaaddabf78c7784f72b3431703fc5ee4a8c |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Deuterosomal|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 1.38e-06 | 182 | 262 | 9 | 000eca5baa6eb2335a1e6d76a13fff5382b0e150 | |
| ToppCell | 18-Airway-Epithelial-Multiciliated_precursor|Airway / Age, Tissue, Lineage and Cell class | 1.44e-06 | 183 | 262 | 9 | a75cda2131755931117c387f2e0ae3394efa8e80 | |
| ToppCell | 10x3'2.3-week_12-13-Myeloid_neutrophil-granulo-eo/baso/mast-basophil|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | HIPK1 JAK2 ZMIZ2 C3AR1 ADGRG3 NAALADL1 C1orf162 ARID3B ZBTB11 | 1.44e-06 | 183 | 262 | 9 | f9a3af96c0fb7d5c4d7df6db8b2c42e322418c08 |
| ToppCell | 5'-Adult-Appendix-Endothelial-lymphatic_endothelial|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | ASAP1 ARHGAP29 NDNF ADGRG3 SLC43A3 RALGAPA2 BCL6B TM4SF1 PHLDB2 | 1.51e-06 | 184 | 262 | 9 | 453295362888c9a59d0e73c7a5b15914c50ff591 |
| ToppCell | ILEUM-inflamed-(7)_Lymphatics|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 1.58e-06 | 185 | 262 | 9 | d711dd2e91cfee723dae1ccb2b910b8cf3becc3b | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_CCDC168|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.58e-06 | 185 | 262 | 9 | 5a0340c25196453f19e424d346efbf66d2c53ac3 | |
| ToppCell | facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.65e-06 | 186 | 262 | 9 | bdc87e4631a8ea73e262e541aa84a28f24c94b00 | |
| ToppCell | COVID-19-kidney-tDL|kidney / Disease (COVID-19 only), tissue and cell type | 1.73e-06 | 187 | 262 | 9 | d35d27ca3c0e65f92f4508e1cb98a743f44fdcdf | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-06 | 187 | 262 | 9 | 9d77ca45f7563bd6f2a0c1be5d99d93ad30983f7 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_PAX6|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.73e-06 | 187 | 262 | 9 | d2ffb2f34f07b0dd5d3cb3ee0275f46ebecf4146 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|kidney / Disease (COVID-19 only), tissue and cell type | 1.73e-06 | 139 | 262 | 8 | 64c35411bbe67acb5010dadc4b0b1be0f8b17737 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_1|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | CNTNAP5 KIDINS220 MAP7D2 ANK3 FAT3 PCLO LRRC4C SEZ6L2 SPHKAP | 1.97e-06 | 190 | 262 | 9 | 6e92c78799f34b31d098854503c796edb0dc7f80 |
| ToppCell | COVID-19-Epithelial_cells-Airway_goblet|COVID-19 / group, cell type (main and fine annotations) | 1.97e-06 | 190 | 262 | 9 | 51ca9ef4df3220487152fcf684147730637c7cc1 | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-Neuroendocrine|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-06 | 191 | 262 | 9 | 501d4f6ad389d9ac5051d4247b9bd3da96f713f9 | |
| ToppCell | facs-Lung-EPCAM-24m-Epithelial-lung_neuroendocrine_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.06e-06 | 191 | 262 | 9 | 8e06cc61eaff1796c2ce014074029408ba88d561 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_C_(IT_L4_RORB)-Exc_L4_RORB_BHLHE22|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.15e-06 | 192 | 262 | 9 | 25460ca9ebd3d49f666394cf99ab77a5e8f77250 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NID1 ADGRG3 SLC43A3 RALGAPA2 CD93 FAM171A1 KLF7 FAM124A TM4SF1 | 2.15e-06 | 192 | 262 | 9 | d525f7f088a53110912600a7c9f6d33b9270d534 |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NID1 ADGRG3 SLC43A3 RALGAPA2 CD93 FAM171A1 KLF7 FAM124A TM4SF1 | 2.15e-06 | 192 | 262 | 9 | 2bfac6b3956265205ca47d06888851ed68b65999 |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD|renal_papilla_nuclei / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 193 | 262 | 9 | ca7c0a4ceb05bced90f6cdc53d278e547fb241e9 | |
| ToppCell | wk_15-18-Epithelial-PNS|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.24e-06 | 193 | 262 | 9 | ca65f8f93058ad50d89e69e06c10deeb46dbfc87 | |
| ToppCell | TCGA-Colorectal-Primary_Tumor-Colorectal_Adenocarcinoma-Colon_Adenocarcinoma-10|TCGA-Colorectal / Sample_Type by Project: Shred V9 | 2.24e-06 | 193 | 262 | 9 | 194e7fa00a50cc4e026987b715323d125d79594e | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.24e-06 | 193 | 262 | 9 | 3866667dd221612589ae50f5c52f73a183a49ce6 | |
| ToppCell | facs-Liver-Non-hepatocytes-24m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADGRG3 SLC43A3 RALGAPA2 CD93 FAM171A1 KLF7 FAM124A TM4SF1 PHLDB2 | 2.34e-06 | 194 | 262 | 9 | c8b9551b93a5aed62154b487db90130604a6125c |
| ToppCell | LV-14._Fibroblast_III|LV / Chamber and Cluster_Paper | 2.34e-06 | 194 | 262 | 9 | 927c26aea0147f7a4b8fb3f192de4de263f1b978 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 195 | 262 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.44e-06 | 195 | 262 | 9 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.44e-06 | 195 | 262 | 9 | 787e95fb59c40bba784544b662fac37606ae1427 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type | 2.50e-06 | 146 | 262 | 8 | c55f1bdb6ac43b4118cb27ea7c879527e1afcbab | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.54e-06 | 196 | 262 | 9 | f374cb3ec31c6eef2cef9e07547bfd1e380553af | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Newborn|World / Primary Cells by Cluster | 2.54e-06 | 196 | 262 | 9 | 9401bd84798f0ea3e986e94135a9e1dc5643330f | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-OPC|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.54e-06 | 196 | 262 | 9 | 671c380b58d7f634b4fbec38c357d357ea4f3535 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.65e-06 | 197 | 262 | 9 | 82b8e22317cad6d3786bd70d91107007c0ccd7cd | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.76e-06 | 198 | 262 | 9 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-endothelial_cell_of_hepatic_sinusoid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | NID1 ADGRG3 FOSB SLC43A3 RALGAPA2 CD93 FAM171A1 TM4SF1 PHLDB2 | 2.76e-06 | 198 | 262 | 9 | f0f1816a0ed3ae8207442602f5cbe4de0382e4b3 |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.77e-06 | 148 | 262 | 8 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_myocytic-Myofibroblastic-MatrixFB_->_Myofibroblast|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 2.88e-06 | 199 | 262 | 9 | 38cfd367ee8c074c11ba54edeb7a001e375e2687 | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type. | 2.88e-06 | 199 | 262 | 9 | 358c4b3037f59378db8916a2fbe9ed4830cf1449 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 2.88e-06 | 199 | 262 | 9 | 77b4aa00f14b86ef5db0490be98787e063979541 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.91e-06 | 149 | 262 | 8 | c5eedb54ef2e0f131aa6730612c921bc19479632 | |
| ToppCell | Smart-seq2-blood_(Smart-seq2)-myeloid-myeloid_granulocytic|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.91e-06 | 149 | 262 | 8 | a22417286de8606f0cc94f86b70bce17aeefb9c2 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW09-Neuronal|GW09 / Sample Type, Dataset, Time_group, and Cell type. | 3.00e-06 | 200 | 262 | 9 | e9eb348a66011d8aace4331f84690ae27cb0d061 | |
| Drug | Estrone [53-16-7]; Up 200; 14.8uM; HL60; HT_HG-U133A | MAK IQSEC2 KIDINS220 ZFYVE9 ARFGAP3 FGFR1 FOSB RUBCNL APC DNAH17 PDE4DIP SNAI1 | 2.45e-06 | 194 | 259 | 12 | 3071_UP |
| Drug | Benzbromarone [3562-84-3]; Down 200; 9.4uM; MCF7; HT_HG-U133A | ZNF609 NXPE3 JAK2 ZFYVE9 HPS4 KCNN2 PLCG1 ARNT ARSB WDCP PDE4DIP QSER1 | 2.72e-06 | 196 | 259 | 12 | 5015_DN |
| Drug | Mebendazole [31431-39-7]; Down 200; 13.6uM; MCF7; HT_HG-U133A | MPDZ PTPRA ALMS1 PGAP1 PDS5A FGFR1 PLCG1 ATG2B APC ARNT C2CD3 PDE4DIP | 3.03e-06 | 198 | 259 | 12 | 4694_DN |
| Drug | Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; HL60; HT_HG-U133A | MAK NXPE3 ZMIZ2 FGFR1 ECI2 NDNF NDST1 ANK3 RUBCNL GRM6 PDE4DIP | 1.04e-05 | 187 | 259 | 11 | 3077_UP |
| Drug | 2-propylpentanoic acid; Up 200; 500uM; PC3; HT_HG-U133A | SCN11A ZMIZ2 C3AR1 DLX2 FAM149B1 APC PTPRU KCNV1 ARNT VCAN PDE4DIP | 1.15e-05 | 189 | 259 | 11 | 4464_UP |
| Drug | Betazole hydrochloride; Up 200; 27uM; PC3; HT_HG-U133A | MPDZ NPFFR1 ASAP1 ITPR1 ZFYVE9 ZMIZ2 PGAP1 FAM149B1 DIP2C CACNG4 SRRM2 | 1.47e-05 | 194 | 259 | 11 | 1812_UP |
| Drug | Indapamide [26807-65-8]; Down 200; 10.6uM; PC3; HT_HG-U133A | ZNF609 MDM2 NPFFR1 MICU1 CNOT3 APC PTPRU ARSB VCAN CACNG4 CABIN1 | 1.47e-05 | 194 | 259 | 11 | 4335_DN |
| Drug | Paromomycin sulfate [1263-89-4]; Down 200; 5.6uM; MCF7; HT_HG-U133A | DENND2B ITPR1 ZFYVE9 CLCN6 ZMIZ2 KCNN2 DLX2 ARNT KLF7 CUZD1 SRRM2 | 1.78e-05 | 198 | 259 | 11 | 3356_DN |
| Drug | Fenoprofen calcium salt dihydrate [53746-45-5]; Up 200; 7.2uM; MCF7; HT_HG-U133A | SOX10 TICAM1 ITPR1 ZFYVE9 SYN2 C3AR1 APC HS2ST1 VCAN CFAP74 TM4SF1 | 1.78e-05 | 198 | 259 | 11 | 3612_UP |
| Drug | Acenocoumarol [152-72-7]; Down 200; 11.4uM; PC3; HT_HG-U133A | TBC1D9B MPDZ LYST NPFFR1 PTPRA ZFYVE9 AGFG1 PDS5A ANK3 PCLO LRRC15 | 1.78e-05 | 198 | 259 | 11 | 5878_DN |
| Drug | bazedoxifene | 2.40e-05 | 51 | 259 | 6 | ctd:C447119 | |
| Drug | AC1L1BWR | 2.55e-05 | 76 | 259 | 7 | CID000001642 | |
| Drug | 0179445-0000 [211246-22-9]; Down 200; 10uM; MCF7; HT_HG-U133A | ZNF609 MPDZ GRHL2 ALMS1 BRCA1 BRCA2 AGFG1 KIF14 DIP2C CACNG4 | 4.70e-05 | 182 | 259 | 10 | 3630_DN |
| Drug | LY 294002; Up 200; 10uM; MCF7; HT_HG-U133A | MAK MDM2 ZFYVE9 ZMIZ2 NID1 SLC43A3 VCAN DNAH17 R3HDM1 TM4SF1 | 6.18e-05 | 188 | 259 | 10 | 5596_UP |
| Drug | Metampicillin sodium salt [6489-61-8]; Up 200; 10.4uM; PC3; HT_HG-U133A | 7.37e-05 | 192 | 259 | 10 | 2123_UP | |
| Drug | Cefalonium [5575-21-3]; Down 200; 8.8uM; PC3; HT_HG-U133A | NPFFR1 FARP2 JAK2 ZMIZ2 SYN2 CNOT3 NDST1 TBC1D17 PDE4DIP CABIN1 | 7.70e-05 | 193 | 259 | 10 | 4245_DN |
| Drug | Niridazole [61-57-4]; Up 200; 18.6uM; MCF7; HT_HG-U133A | 8.04e-05 | 194 | 259 | 10 | 3301_UP | |
| Drug | STOCK1N-35874; Up 200; 14uM; PC3; HT_HG-U133A | 8.39e-05 | 195 | 259 | 10 | 6561_UP | |
| Drug | Adiphenine hydrochloride [50-42-0]; Up 200; 11.4uM; PC3; HT_HG-U133A | EYA4 HIPK1 ITPR1 JAK2 KIDINS220 ZFYVE9 PGAP1 VPS13A FAM149B1 SRRM2 | 8.39e-05 | 195 | 259 | 10 | 1831_UP |
| Drug | Fluticasone propionate [80474-14-2]; Down 200; 8uM; PC3; HT_HG-U133A | 8.39e-05 | 195 | 259 | 10 | 4011_DN | |
| Drug | Flufenamic acid [530-78-9]; Up 200; 14.2uM; PC3; HT_HG-U133A | 8.39e-05 | 195 | 259 | 10 | 2104_UP | |
| Drug | Pentetic acid [67-43-6]; Up 200; 10.2uM; HL60; HT_HG-U133A | 8.75e-05 | 196 | 259 | 10 | 3049_UP | |
| Drug | Epivincamine [6835-99-0]; Down 200; 11.2uM; MCF7; HT_HG-U133A | TICAM1 MDM2 LYST NPFFR1 DENND2B FGFR1 TBC1D17 ARNT PDE4DIP QSER1 | 8.75e-05 | 196 | 259 | 10 | 2775_DN |
| Drug | AH6809; Down 200; 1uM; PC3; HT_HG-U133A | 8.75e-05 | 196 | 259 | 10 | 7049_DN | |
| Drug | Equilin [474-86-2]; Up 200; 15uM; MCF7; HT_HG-U133A | 8.75e-05 | 196 | 259 | 10 | 5255_UP | |
| Drug | (-)-Adenosine 3',5'-cyclic monophosphate [60-92-4]; Up 200; 12.2uM; MCF7; HT_HG-U133A | 8.75e-05 | 196 | 259 | 10 | 5533_UP | |
| Drug | Carbimazole [22232-54-8]; Up 200; 21.4uM; MCF7; HT_HG-U133A | 9.13e-05 | 197 | 259 | 10 | 3299_UP | |
| Drug | Prilocaine hydrochloride [1786-81-8]; Down 200; 15.6uM; PC3; HT_HG-U133A | IQSEC2 SREBF1 BRCA1 DLX2 FGFR1 IFT22 ANK3 CACNG4 TM4SF1 LRRC15 | 9.13e-05 | 197 | 259 | 10 | 3727_DN |
| Drug | Norgestrel-(-)-D [797-63-7]; Down 200; 12.8uM; PC3; HT_HG-U133A | TICAM1 IQSEC2 NPFFR1 FGFR1 DOP1B IFT22 APC PDE4DIP CACNG4 CABIN1 | 9.13e-05 | 197 | 259 | 10 | 3708_DN |
| Drug | Naringin hydrate [11032-30-7]; Up 200; 6.6uM; MCF7; HT_HG-U133A | 9.52e-05 | 198 | 259 | 10 | 3286_UP | |
| Drug | Adenosine 5'-monophosphate monohydrate [18422-05-4]; Up 200; 11uM; MCF7; HT_HG-U133A | 9.52e-05 | 198 | 259 | 10 | 3237_UP | |
| Drug | (1)-Nipecotic acid [498-95-3]; Down 200; 31uM; PC3; HT_HG-U133A | TBC1D9B MPDZ ALMS1 BRCA1 PGAP1 VPS13A DLX2 FGFR1 SLC43A3 R3HDM1 | 9.52e-05 | 198 | 259 | 10 | 7296_DN |
| Drug | Dequalinium dichloride [522-51-0]; Up 200; 7.6uM; PC3; HT_HG-U133A | PDGFRB CLCN6 CCR4 FGFR1 NDNF GRM6 TBC1D17 ASTN1 CACNG4 CABIN1 | 9.52e-05 | 198 | 259 | 10 | 6296_UP |
| Drug | Isoxicam [34552-84-6]; Down 200; 12uM; MCF7; HT_HG-U133A | IQSEC2 FGFR1 FAM149B1 CNOT3 DOP1B NDST1 IFT22 SEZ6L2 ARNT MTMR9 | 9.52e-05 | 198 | 259 | 10 | 7028_DN |
| Drug | (+/-)-thalidomide; Down 200; 100uM; MCF7; HG-U133A | 9.52e-05 | 198 | 259 | 10 | 266_DN | |
| Drug | Moxalactam disodium salt [64953-12-4]; Down 200; 7uM; MCF7; HT_HG-U133A | TICAM1 WNK1 KIDINS220 CLCN6 FGFR1 PLCG1 PDE4DIP CUZD1 CACNG4 CABIN1 | 9.52e-05 | 198 | 259 | 10 | 5609_DN |
| Drug | Austricine [10180-88-8]; Up 200; 14.2uM; PC3; HT_HG-U133A | 9.92e-05 | 199 | 259 | 10 | 4213_UP | |
| Drug | Fosfosal [6064-83-1]; Up 200; 18.4uM; MCF7; HT_HG-U133A | ZNF609 IQSEC2 JAK2 KIDINS220 PLCG1 CNOT3 APC PDE4DIP CUZD1 CABIN1 | 9.92e-05 | 199 | 259 | 10 | 4823_UP |
| Drug | Alfuzosin hydrochloride [81403-68-1]; Down 200; 9.4uM; MCF7; HT_HG-U133A | ZNF609 TICAM1 IQSEC2 LYST PGAP1 LAMB1 TBC1D17 KLF7 PDE4DIP SRRM2 | 9.92e-05 | 199 | 259 | 10 | 3203_DN |
| Drug | Clidinium bromide [3485-62-9]; Up 200; 9.2uM; MCF7; HT_HG-U133A | 9.92e-05 | 199 | 259 | 10 | 3476_UP | |
| Drug | Dihydrostreptomycin sulfate [5490-27-7]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 9.92e-05 | 199 | 259 | 10 | 2237_DN | |
| Disease | Colorectal Carcinoma | EYA4 ERCC6 ABCA13 WNK1 CSMD3 F5 NDST3 PTPRD VPS13A NID1 ATP11C PZP IQUB ANK2 POLE APC PTPRU PTPRT CD93 ARNT DIP2C MTDH CUX1 EXOC4 | 1.19e-08 | 702 | 254 | 24 | C0009402 |
| Disease | Schizophrenia | SOX10 DGCR6 MYO5B PDGFRB ABCA13 SREBF1 NFASC CMYA5 ZDHHC8 CHRNA7 CACNG2 NDST3 PTPRA BRCA1 PTPRZ1 HPS4 SYN2 FGFR1 MAGEC1 CHRFAM7A ANK3 APC RELA DICER1 EGR2 CGNL1 MEGF10 | 1.44e-08 | 883 | 254 | 27 | C0036341 |
| Disease | hearing impairment | 1.82e-07 | 98 | 254 | 9 | C1384666 | |
| Disease | Malignant neoplasm of breast | NAT2 TBC1D9B ERCC6 TICAM1 MDM2 WNK1 FASN PTPRD BRCA1 BRCA2 ARFGAP3 ARHGAP29 MAP7D2 NHS BOD1L1 FGFR1 MAGEC2 ANK2 UBR4 RELA GRM6 WDCP DIP2C TEKT4 SNAI1 MTDH CUX1 | 7.18e-07 | 1074 | 254 | 27 | C0006142 |
| Disease | Benign tumor of pancreas | 3.61e-06 | 13 | 254 | 4 | C0347284 | |
| Disease | Nonsyndromic Deafness | 6.52e-06 | 81 | 254 | 7 | C3711374 | |
| Disease | colorectal cancer (is_marker_for) | 9.42e-06 | 157 | 254 | 9 | DOID:9256 (is_marker_for) | |
| Disease | insulin resistance | 1.18e-05 | 59 | 254 | 6 | EFO_0002614 | |
| Disease | Pancreatic carcinoma | 1.88e-05 | 19 | 254 | 4 | C0235974 | |
| Disease | lung non-small cell carcinoma (is_implicated_in) | 2.88e-05 | 139 | 254 | 8 | DOID:3908 (is_implicated_in) | |
| Disease | Liver carcinoma | NAT2 SREBF1 FASN KCNN2 KIF14 C9 PZP MAGEC2 HNF1A FOSB DTL APC THY1 EGR2 KIF18B | 3.82e-05 | 507 | 254 | 15 | C2239176 |
| Disease | ductal carcinoma in situ (biomarker_via_orthology) | 7.38e-05 | 2 | 254 | 2 | DOID:0060074 (biomarker_via_orthology) | |
| Disease | Hereditary site-specific ovarian cancer syndrome | 7.38e-05 | 2 | 254 | 2 | C4749652 | |
| Disease | Hepatic Vein Thrombosis | 7.38e-05 | 2 | 254 | 2 | C0019154 | |
| Disease | level of low affinity immunoglobulin gamma Fc region receptor III-A in blood serum | 7.38e-05 | 2 | 254 | 2 | OBA_2040305 | |
| Disease | Budd-Chiari syndrome | 7.38e-05 | 2 | 254 | 2 | cv:C0856761 | |
| Disease | BUDD-CHIARI SYNDROME | 7.38e-05 | 2 | 254 | 2 | 600880 | |
| Disease | Budd-Chiari Syndrome | 7.38e-05 | 2 | 254 | 2 | C0856761 | |
| Disease | cerebellar volume measurement | 8.49e-05 | 52 | 254 | 5 | EFO_0020864 | |
| Disease | colorectal cancer (is_implicated_in) | 8.84e-05 | 121 | 254 | 7 | DOID:9256 (is_implicated_in) | |
| Disease | complement factor H-related protein 3 measurement | 1.14e-04 | 169 | 254 | 8 | EFO_0600056 | |
| Disease | Malignant Neoplasms | 1.26e-04 | 128 | 254 | 7 | C0006826 | |
| Disease | RS-warfarin measurement | 1.26e-04 | 128 | 254 | 7 | EFO_0803325 | |
| Disease | Myeloproliferative disease | 1.31e-04 | 12 | 254 | 3 | C0027022 | |
| Disease | Lupus Vasculitis, Central Nervous System | 2.20e-04 | 3 | 254 | 2 | C0752332 | |
| Disease | Lupus Meningoencephalitis | 2.20e-04 | 3 | 254 | 2 | C0752334 | |
| Disease | Neuropsychiatric Systemic Lupus Erythematosus | 2.20e-04 | 3 | 254 | 2 | C0752335 | |
| Disease | Budd-Chiari syndrome (is_implicated_in) | 2.20e-04 | 3 | 254 | 2 | DOID:11512 (is_implicated_in) | |
| Disease | Liver neoplasms | 2.39e-04 | 142 | 254 | 7 | C0023903 | |
| Disease | Malignant neoplasm of liver | 2.39e-04 | 142 | 254 | 7 | C0345904 | |
| Disease | Bipolar Disorder | ABCA13 CHRNA7 ITPR1 NDST3 BRCA2 FGFR1 PLCG1 CHRFAM7A ANK3 PCLO EGR2 ASMT SEZ6L | 2.78e-04 | 477 | 254 | 13 | C0005586 |
| Disease | Hereditary hearing loss and deafness | 2.83e-04 | 146 | 254 | 7 | cv:C0236038 | |
| Disease | schizophrenia (implicated_via_orthology) | 3.04e-04 | 68 | 254 | 5 | DOID:5419 (implicated_via_orthology) | |
| Disease | renal cell carcinoma (is_implicated_in) | 3.26e-04 | 69 | 254 | 5 | DOID:4450 (is_implicated_in) | |
| Disease | serum gamma-glutamyl transferase measurement | NAT2 CSMD3 DENND2B ITPR1 MICU1 FARP2 FCGR3A FCGR3B ZMIZ2 KCNN2 SYN2 PLCG1 MED13 KLB HNF1A CGNL1 CABIN1 EXOC4 PLCE1 | 3.92e-04 | 914 | 254 | 19 | EFO_0004532 |
| Disease | triacylglycerol 56:9 measurement | 3.92e-04 | 17 | 254 | 3 | EFO_0010436 | |
| Disease | myeloproliferative neoplasm (implicated_via_orthology) | 4.38e-04 | 4 | 254 | 2 | DOID:2226 (implicated_via_orthology) | |
| Disease | Hereditary breast ovarian cancer syndrome | 4.38e-04 | 4 | 254 | 2 | cv:C0677776 | |
| Disease | liver cancer (implicated_via_orthology) | 4.38e-04 | 4 | 254 | 2 | DOID:3571 (implicated_via_orthology) | |
| Disease | Autistic Disorder | 4.64e-04 | 261 | 254 | 9 | C0004352 | |
| Disease | intellectual disability (implicated_via_orthology) | 4.80e-04 | 75 | 254 | 5 | DOID:1059 (implicated_via_orthology) | |
| Disease | Nonsyndromic genetic hearing loss | 5.10e-04 | 76 | 254 | 5 | cv:C5680182 | |
| Disease | Disorder of eye | 5.30e-04 | 212 | 254 | 8 | C0015397 | |
| Disease | Intellectual Disability | PDGFRB KDM3B FASN BRCA1 TET3 MED13 NDST1 DOCK8 APC KLF7 ASTN1 ZBTB11 | 5.43e-04 | 447 | 254 | 12 | C3714756 |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 6.05e-04 | 45 | 254 | 4 | DOID:3748 (is_implicated_in) | |
| Disease | Gastrointestinal Stromal Sarcoma | 7.15e-04 | 47 | 254 | 4 | C3179349 | |
| Disease | proline measurement, amino acid measurement | 7.26e-04 | 5 | 254 | 2 | EFO_0005134, EFO_0009773 | |
| Disease | Usher Syndrome, Type II | 7.26e-04 | 5 | 254 | 2 | C1568249 | |
| Disease | hereditary breast ovarian cancer syndrome (is_implicated_in) | 7.26e-04 | 5 | 254 | 2 | DOID:5683 (is_implicated_in) | |
| Disease | Infiltrating duct carcinoma of female breast | 7.47e-04 | 21 | 254 | 3 | C3165106 | |
| Disease | Gastrointestinal Stromal Tumors | 9.05e-04 | 50 | 254 | 4 | C0238198 | |
| Disease | bone mineral content measurement | 9.40e-04 | 130 | 254 | 6 | EFO_0007621 | |
| Disease | Glioma | 9.45e-04 | 87 | 254 | 5 | C0017638 | |
| Disease | waist-hip ratio | EYA4 EYA1 WNK1 SSC5D KIDINS220 PTPRD NID1 FGFR1 IQUB SHISA6 PRUNE2 NDST1 ANK3 LAMB1 DNAH17 CAPRIN2 KCNK5 DOT1L LRRC36 CUX1 PHLDB2 PLCE1 | 9.94e-04 | 1226 | 254 | 22 | EFO_0004343 |
| Disease | hepatocellular carcinoma (is_implicated_in) | 1.02e-03 | 181 | 254 | 7 | DOID:684 (is_implicated_in) | |
| Disease | cognitive disorder (implicated_via_orthology) | 1.08e-03 | 6 | 254 | 2 | DOID:1561 (implicated_via_orthology) | |
| Disease | extraversion | 1.08e-03 | 6 | 254 | 2 | EFO_0004317 | |
| Disease | Liposarcoma, well differentiated | 1.08e-03 | 6 | 254 | 2 | C1370889 | |
| Disease | Liposarcoma, Dedifferentiated | 1.08e-03 | 6 | 254 | 2 | C0205824 | |
| Disease | Adult only | 1.08e-03 | 6 | 254 | 2 | C3842001 | |
| Disease | Orofaciodigital Syndromes | 1.08e-03 | 6 | 254 | 2 | C0029294 | |
| Disease | rheumatoid arthritis (biomarker_via_orthology) | 1.08e-03 | 6 | 254 | 2 | DOID:7148 (biomarker_via_orthology) | |
| Disease | eye disease (implicated_via_orthology) | 1.08e-03 | 6 | 254 | 2 | DOID:5614 (implicated_via_orthology) | |
| Disease | airway responsiveness measurement | 1.12e-03 | 24 | 254 | 3 | EFO_0006897 | |
| Disease | triacylglycerol 56:4 measurement | 1.12e-03 | 24 | 254 | 3 | EFO_0010431 | |
| Disease | nevus count, cutaneous melanoma | 1.16e-03 | 91 | 254 | 5 | EFO_0000389, EFO_0004632 | |
| Disease | breast cancer (implicated_via_orthology) | 1.26e-03 | 25 | 254 | 3 | DOID:1612 (implicated_via_orthology) | |
| Disease | TEMPS-A questionnaire | 1.26e-03 | 25 | 254 | 3 | EFO_0004783 | |
| Disease | methionine measurement | 1.42e-03 | 26 | 254 | 3 | EFO_0009771 | |
| Disease | Pilomyxoid astrocytoma | 1.51e-03 | 7 | 254 | 2 | C1519086 | |
| Disease | ductal carcinoma in situ (is_implicated_in) | 1.51e-03 | 7 | 254 | 2 | DOID:0060074 (is_implicated_in) | |
| Disease | myeloid neoplasm (is_implicated_in) | 1.51e-03 | 7 | 254 | 2 | DOID:0070004 (is_implicated_in) | |
| Disease | low affinity immunoglobulin gamma Fc region receptor II-a/b measurement | 1.51e-03 | 7 | 254 | 2 | EFO_0008211 | |
| Disease | branchiootorenal syndrome (implicated_via_orthology) | 1.51e-03 | 7 | 254 | 2 | DOID:14702 (implicated_via_orthology) | |
| Disease | pulmonary venoocclusive disease (biomarker_via_orthology) | 1.51e-03 | 7 | 254 | 2 | DOID:5453 (biomarker_via_orthology) | |
| Disease | irritable bowel syndrome symptom measurement | 1.58e-03 | 58 | 254 | 4 | EFO_0021536 | |
| Disease | azoospermia (implicated_via_orthology) | 1.58e-03 | 27 | 254 | 3 | DOID:14227 (implicated_via_orthology) | |
| Disease | testosterone measurement | DCHS2 TPRN IQSEC2 EYA1 CSMD3 FARP2 FASN FAM186A PGAP1 FGFR1 PLCG1 USH2A DAGLB HNF1A ANK2 ANK3 ARNT EGR2 DUSP16 RORB LRRC36 RNF212B | 1.63e-03 | 1275 | 254 | 22 | EFO_0004908 |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 1.68e-03 | 99 | 254 | 5 | EFO_0004611, EFO_0007878 | |
| Disease | stimulant use measurement | 1.76e-03 | 28 | 254 | 3 | EFO_0600076 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 1.92e-03 | 102 | 254 | 5 | EFO_0004329, EFO_0004611 | |
| Disease | Neoplasm of uncertain or unknown behavior of ovary | 1.95e-03 | 29 | 254 | 3 | C0496920 | |
| Disease | Movement Disorders | 1.95e-03 | 29 | 254 | 3 | C0026650 | |
| Disease | Autistic behavior | 2.00e-03 | 8 | 254 | 2 | C0856975 | |
| Disease | ovarian cancer (implicated_via_orthology) | 2.00e-03 | 8 | 254 | 2 | DOID:2394 (implicated_via_orthology) | |
| Disease | Hypermetropia | 2.00e-03 | 103 | 254 | 5 | HP_0000540 | |
| Disease | serum IgG glycosylation measurement | CNTNAP5 CFAP92 ARHGAP29 USH2A SHISA6 LAMB1 LRRC4C RALGAPA2 PTPRT EGR2 LPO MEGF10 | 2.06e-03 | 523 | 254 | 12 | EFO_0005193 |
| Disease | Retinitis Pigmentosa | 2.09e-03 | 104 | 254 | 5 | C0035334 | |
| Disease | Ovarian Carcinoma | 2.16e-03 | 30 | 254 | 3 | C0029925 | |
| Disease | Myopathy | 2.16e-03 | 30 | 254 | 3 | C0026848 | |
| Disease | Age related macular degeneration | 2.16e-03 | 30 | 254 | 3 | C0242383 | |
| Disease | Malignant neoplasm of lung | 2.25e-03 | 266 | 254 | 8 | C0242379 | |
| Disease | transient cerebral ischemia (biomarker_via_orthology) | 2.46e-03 | 157 | 254 | 6 | DOID:224 (biomarker_via_orthology) | |
| Disease | anti-centromere-antibody-positive systemic scleroderma | 2.55e-03 | 9 | 254 | 2 | EFO_0008536 | |
| Disease | Pancreatic carcinoma, familial | 2.55e-03 | 9 | 254 | 2 | C2931038 | |
| Disease | isovalerate measurement | 2.55e-03 | 9 | 254 | 2 | EFO_0021051 | |
| Disease | plexin-B2 measurement | 2.55e-03 | 9 | 254 | 2 | EFO_0021867 | |
| Disease | birth weight | FCGR3A FCGR3B FGFR1 PLCG1 USH2A HNF1A DTL PCDHB16 PLEKHA1 PLCE1 | 2.56e-03 | 399 | 254 | 10 | EFO_0004344 |
| Disease | triacylglycerol 54:5 measurement | 2.60e-03 | 32 | 254 | 3 | EFO_0010423 | |
| Disease | Endometrioma | 2.78e-03 | 161 | 254 | 6 | C0269102 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| PTSITSAAFTLRTQY | 281 | Q8IVW6 | |
| TSSFTFQNPYSDEIE | 441 | P27540 | |
| VNSPISITSYYSAED | 306 | Q6NVV9 | |
| TSSSSYFDEPVELRS | 351 | Q9NP61 | |
| TYSTDGQTVLPLTSD | 116 | A6NF34 | |
| IPSSLFSTTHETSLY | 2186 | Q7Z407 | |
| ISLSGDYSSAFNITS | 2526 | Q7Z407 | |
| SYSSTQEPTTYVDSS | 956 | P13611 | |
| TSSYTPDKSSFNLAT | 241 | Q99708 | |
| IPISLFDDTSYTSND | 351 | Q9NZJ5 | |
| STTNSFLPTAEIIYT | 1166 | Q9P2K8 | |
| SQSIPIFATDYTTIS | 271 | Q8IZF6 | |
| DSQSVSDSLYYPDSL | 146 | Q8IUR6 | |
| ESPYSQSSELSLTGA | 886 | P39880 | |
| PYTLAVANTTFTVST | 321 | Q9H2F3 | |
| FSSHTYSQASELPTD | 416 | Q9NWN3 | |
| SLSSDDPDSYVTLTV | 4046 | Q8WXG9 | |
| YVTADFISQSSSASP | 4431 | Q8WXG9 | |
| DQKTEFPAATLSSYS | 2006 | Q8TCU4 | |
| YTTPFQTTSSSLEAV | 201 | Q9NPY3 | |
| VTLSLSTLPSDSYYS | 131 | Q5T7R7 | |
| STLPSDSYYSQSIEA | 136 | Q5T7R7 | |
| NYSTSEESSFVFPLA | 1111 | Q86UQ4 | |
| FTILYLPSQSTTVSS | 521 | Q86Y34 | |
| ASSESSYPTAESQAE | 296 | Q53GS7 | |
| DTDTFLDTLTTYPIT | 301 | P0C7M7 | |
| QIYSADTPSSSYTQS | 336 | P51679 | |
| SLDYSSEPATVTQVT | 161 | P20073 | |
| NTELSSDYLTTVSPT | 86 | P46597 | |
| EPISSITSFYQSTSE | 16 | Q9ULG3 | |
| NSTFYVKSSLSPDDQ | 316 | Q9NZJ0 | |
| VSQTAASSPQDAYRS | 441 | Q8TEK3 | |
| EYAISTSPFTSNETN | 876 | Q6Q4G3 | |
| PSSFQQRLSYTTLSD | 36 | Q14129 | |
| DSEQSPSIGYSSRTL | 1276 | Q9UPY3 | |
| KISLSPFSTTDSAYE | 1466 | Q9UPY3 | |
| EFEDASSLQSLYPSS | 451 | P78524 | |
| LFPSASSNSFYESEL | 296 | Q16581 | |
| SSDPVVGTLSSSYLD | 121 | Q8WU49 | |
| LPVSTATDSSYYTNQ | 56 | Q07687 | |
| LYELFTLTSPDASQS | 1001 | Q03468 | |
| LTFPEYITSLSDSGT | 916 | O14525 | |
| SEQSFYETETARTPS | 386 | Q96BY7 | |
| TSDSVPLIAQYFAST | 286 | P36544 | |
| ETTLQSTYSDTSAQP | 11 | Q9ULX6 | |
| ATSYSSVVADSPAEV | 426 | O75175 | |
| TDPTVLVFVESQYSS | 76 | O95803 | |
| SQVVSRSSSAESIPY | 171 | A8MTL3 | |
| STYTVLATFPSISAA | 1051 | Q15032 | |
| LFASFPTEESSINYT | 2596 | P49792 | |
| ILLSASDSNSTEPQY | 16 | P20742 | |
| SSKSVTYEPDFNSAE | 326 | Q9H714 | |
| PTSFHSAETYESLLQ | 671 | Q29RF7 | |
| QTPQAYSSTLFTSST | 161 | Q2KHR3 | |
| VSVELAQSYSSAIPS | 256 | Q2KHR3 | |
| SASFPTEESSINYTF | 1621 | Q99666 | |
| SASFPTEESSINYTF | 1621 | O14715 | |
| LYQDPSAFLSAATTS | 181 | P11161 | |
| YAPESLTESKFSVAS | 1021 | O60674 | |
| STADPSIFVATYVSV | 131 | Q9HCM3 | |
| EYFVTTPGTETSETQ | 3771 | Q01484 | |
| ATTPTATYNSDRDNS | 281 | Q9Y698 | |
| SLSRTSTALPADSYQ | 841 | Q96KG7 | |
| NTEATPATNLTFSSY | 21 | Q9GZQ6 | |
| FSQPSYADTLISRES | 801 | Q9Y5G9 | |
| YISPSGTELSSLEQT | 36 | Q96DN6 | |
| LASDFYSDFSVPSTS | 1541 | Q15058 | |
| LPENTSYSDLTAFLT | 156 | Q5VUB5 | |
| SYSDLTAFLTAASSP | 161 | Q5VUB5 | |
| TELSSQTPYTLNFSF | 1316 | Q9ULH0 | |
| NDESDVTSTLSYILP | 1111 | O60309 | |
| PVSSSFSYTLLSLFQ | 446 | O60732 | |
| SASSTLYLVFSPSSF | 41 | Q9UBF1 | |
| AYSDTSPFLILSEAS | 206 | Q5VT66 | |
| SSSTVAISYSPDRVF | 186 | Q96T17 | |
| NSVATYLPITATSAT | 2461 | Q2M2H8 | |
| YLPITATSATTDTTN | 2466 | Q2M2H8 | |
| VTTFFSSPFSDQSTT | 1496 | Q14643 | |
| STNFQIISSYPDDES | 61 | Q8TD10 | |
| SFLPEQEFELYSSAT | 126 | Q96QG7 | |
| LESLDLSYNPIFSSS | 96 | A6NIV6 | |
| YVTVNDSPDSDSSLS | 936 | Q86Z02 | |
| LAFSYAPSTTTADVD | 241 | Q9H2S1 | |
| TDYTLTISSLQPEDF | 91 | A0A0B4J1Z2 | |
| VSSSAPSVYSVQALS | 1886 | Q9Y3R5 | |
| EDSSATSFSDLPLYL | 506 | Q5JU85 | |
| SESNIYSPLTSFITA | 351 | Q8N6Q8 | |
| SSTSAYSSFPVDVVV | 4031 | Q2LD37 | |
| LNFDLSSPTSTLSNY | 366 | B1AK53 | |
| PRDEAASTSSTYNFT | 591 | Q9NQG7 | |
| STYVTADNPTDDTAT | 46 | Q8NDZ0 | |
| NTYPVSDDSILSSDS | 541 | Q5CZC0 | |
| LTEFTSLPRSSSDYS | 4121 | Q5CZC0 | |
| TPFFTVYISADSKSS | 276 | P0DPD6 | |
| SSSDLSVVSAYSAPS | 421 | Q86V42 | |
| STVEYFAEQSIPDTT | 361 | Q6PIU1 | |
| TYSTSIIPNATLSSS | 411 | Q5SYE7 | |
| ATPSQSDTSSVKSEY | 766 | Q5SYE7 | |
| FSDYIFLTTVLSTPQ | 206 | Q9BPX6 | |
| PDISATYASSRFSDS | 756 | Q9P2D6 | |
| SLKPSSSIDEYFSEQ | 471 | P17181 | |
| SLILTYSEPSESATS | 2161 | Q9Y6V0 | |
| ADSDTQSPQYLSATS | 3571 | Q9Y6V0 | |
| TFTSTESELSVPYEQ | 471 | O95279 | |
| LSSDLYATTHFNSDP | 396 | Q1X8D7 | |
| SSLTTALTEITPFSY | 2746 | Q02505 | |
| TSFLDASFVYSSEPS | 301 | P22079 | |
| AVLASSDSSSYAIFL | 181 | P14543 | |
| TSQAVTDPTAEYSTI | 266 | Q99502 | |
| TSFLLSVYAPGSSVE | 161 | P36980 | |
| NESRTSSTFPSVYTI | 376 | Q99550 | |
| SSTFPSVYTITSNDI | 381 | Q99550 | |
| SSNYPSSETFEEIQF | 631 | P52848 | |
| SYVQTEISTSLFSPN | 161 | Q5T7B8 | |
| EISTSLFSPNYLSAI | 166 | Q5T7B8 | |
| SQTLPTSNYFTTVSE | 531 | Q7LBC6 | |
| ISYIPTLSSFNLFSS | 201 | Q8IV20 | |
| NDVEYFISSSSPSGL | 131 | Q8TB73 | |
| ASPTVSSSSLVLYQS | 586 | P20823 | |
| QYTSSDSDVESPYTL | 686 | P07942 | |
| SLQPASSSLDSYTAV | 111 | O75840 | |
| LNVTAATTTPFSYFS | 441 | Q9HCJ2 | |
| ATTTPFSYFSTVTVE | 446 | Q9HCJ2 | |
| PSSLTYVTRSENSIF | 916 | Q07864 | |
| PSVDVSFESILSSYD | 801 | P23471 | |
| LNISSPVSVAEFTYT | 1016 | P23471 | |
| LSPSTQLLFYETSAS | 1161 | P23471 | |
| SLSFVDASYSSSVTP | 71 | Q8NGF4 | |
| FNDSTLISYLQTPTE | 1431 | Q2PPJ7 | |
| AAISPSSLTYEDTYN | 326 | Q86Y91 | |
| TSDSVPLIAQYFAST | 196 | Q494W8 | |
| FSVPVSYRNASSLDS | 646 | O14522 | |
| TEITTNISAPSFDYA | 581 | Q92729 | |
| SDSTISTLETPQDYI | 676 | Q8IV76 | |
| FNPSTYVTSISDETQ | 771 | Q6V1P9 | |
| TLSPSDYFSLDVEAS | 171 | Q9Y5I3 | |
| DNAPTFTQTSYTLFV | 446 | Q9Y5F2 | |
| SSSPSAESQYLSSVD | 16 | P53539 | |
| DNAPTFTQTSYTLFV | 446 | Q9NRJ7 | |
| NESSEATSPVNAIYS | 1331 | O94856 | |
| DIDDNSPVFTNSTYT | 811 | Q96QU1 | |
| DNAPTFTQTSYTLFV | 446 | Q9Y5E9 | |
| SVDSNLLSDYTSFPE | 366 | Q9Y236 | |
| TTAPITISSLAEYSN | 856 | Q52LW3 | |
| LSASFPTEESSINYT | 1621 | A6NKT7 | |
| SNSYPSIISDSSALE | 1426 | P38398 | |
| STTNDYTPQVSAITD | 2076 | Q8NFC6 | |
| TRTASEPSAQLSYAS | 406 | Q96A65 | |
| PSTSVSLTTAVQDYV | 461 | Q96EP1 | |
| SESQSSASQPRLSYA | 761 | P51797 | |
| DGTPSSTSTYQLQES | 301 | O95677 | |
| NFLTESSDITEYSPT | 21 | Q9H7X7 | |
| TPDSTYSESFKDAAT | 211 | Q6ISB3 | |
| QISYASTAPELSDST | 171 | O15303 | |
| ASTPYLLTSQAQDTS | 271 | Q8N143 | |
| AEPVVSYTSVATTSF | 336 | Q9Y6J0 | |
| VSFATADESSPVYTQ | 1666 | Q4AC94 | |
| SSQARSAVFSVTYPS | 326 | Q8NF50 | |
| SESTRTAPTSSEDYL | 3366 | P51587 | |
| VTTAASYSPDQEASF | 286 | Q9UBN1 | |
| EFSKSYEESSPSTSI | 3861 | Q9UFH2 | |
| YEESSPSTSIFFILS | 3866 | Q9UFH2 | |
| APVSYTFSKDSTVAS | 1286 | Q0VF96 | |
| TTYFSVNVSDALPSS | 111 | P11362 | |
| FSTYFSDTDLVPSDI | 221 | Q8NCG7 | |
| ERYTPSSTSASEFSV | 891 | Q8N3K9 | |
| SSSEDALEYYKPSTT | 421 | Q9BY84 | |
| IFDQPTYNTTLSEAS | 2286 | Q8TDW7 | |
| PSFTQSQYSFTIAED | 2706 | Q8TDW7 | |
| PDTLAYLDFSVSTTG | 1131 | Q9Y2E4 | |
| TPSSEEVSYEFTSKT | 3171 | Q12955 | |
| IAETTEDYNSPTTSS | 31 | Q9ULH1 | |
| EDYNSPTTSSFTTRL | 36 | Q9ULH1 | |
| PSSFQQRLSYTTLSD | 36 | Q9BY27 | |
| STLSSAASPSQAYET | 106 | Q6IMN6 | |
| AELSSSLSSPSYRFQ | 661 | Q99698 | |
| AYTNRFTSSTPSEIE | 3591 | Q99698 | |
| SDSELSTAPTSKQYY | 466 | P20794 | |
| LISSQASSYFIDAAT | 66 | O75015 | |
| SSASSSLETPVRLYQ | 51 | Q6UX82 | |
| STAEPVSQSTTSDYQ | 351 | Q86UE4 | |
| LYLPSTEFSVSSTSR | 606 | Q8NA54 | |
| DSSLPEYSAFNTSVH | 416 | P15848 | |
| NTYLQTSPTSSFITT | 206 | P11245 | |
| SSDSFGEEQSTTYLP | 86 | Q86Y33 | |
| VSSTNGSSDSYIFLE | 121 | Q86Z14 | |
| ALLSVQYSSTSSDRP | 51 | Q14CZ8 | |
| YVDLVSSLSPSLESS | 111 | O75521 | |
| FHSATYTTISQLPDT | 841 | Q8NDH2 | |
| DYVPVFESSSSTLTF | 111 | Q86UP6 | |
| STLLSYESTDPVINN | 776 | A6NE01 | |
| PDLGQSSSLYVSSSE | 161 | Q3B820 | |
| SSSLYVSSSEEELPN | 166 | Q3B820 | |
| SSANAFYSLSPSTLV | 401 | O94887 | |
| LISSQASSYFIDAAT | 66 | P08637 | |
| SPSAAIYNIDTSSES | 856 | P49327 | |
| SSIPGESLTYASTTF | 111 | Q8NEQ5 | |
| SYENTDLSLTDPESF | 1971 | Q9C0D2 | |
| NTSSSPVYYSTTREE | 2131 | Q6ZTR5 | |
| TTVPTNTYTLDYEAA | 406 | Q9C0B2 | |
| NISLSSSAIYTDSAP | 1021 | Q8WYK1 | |
| AQYTTSYDPELTESS | 21 | P02748 | |
| FSLVPSLTVNTTEYE | 671 | Q5VW36 | |
| APESIFNSLYTTLSD | 871 | P09619 | |
| YSSSDDVIELTPSNF | 21 | Q15084 | |
| LGPTYLTTVNSSDSD | 71 | P18433 | |
| QPETSYSLTVTAYTT | 791 | P23468 | |
| SPSAVSASYETTLSQ | 161 | Q96BN6 | |
| TFDSSPEAAQQTYSL | 211 | Q7L3T8 | |
| ALTQTYATAEPFIDS | 296 | Q92777 | |
| PFSSTEYSSSVDSSL | 81 | A2RUB1 | |
| FSNPSASLSYEVSDL | 2486 | O75445 | |
| PSKQSSTESITEEFY | 1181 | Q2M3C7 | |
| LYSSTPDLTIQFHSD | 706 | Q9BYH1 | |
| SRFQSDSSSYPTVDS | 1136 | Q9UQ35 | |
| SPLDTNYSTSDSYTS | 961 | Q8WUY3 | |
| FDLSYLTEPAQSAET | 2396 | Q8WUY3 | |
| TTFTTLPSEELAYDS | 1016 | Q6IEE7 | |
| AQYITLSETFPSLFS | 936 | B5MCY1 | |
| ALAIPTDSSSEFQVY | 1031 | B5MCY1 | |
| TFSPYEDEVNSSFTS | 451 | P12259 | |
| SVSSTTELTSPVEDY | 501 | Q8TF66 | |
| VSVASYELTQPSSVS | 16 | P01718 | |
| TISYESEITSVNSFP | 1356 | Q6T4R5 | |
| TDPSSSYFVILNSAA | 101 | Q969Y0 | |
| SAPLYTNLTIDENTS | 1251 | Q9P212 | |
| DFTPRSSTVEASVSY | 571 | P48764 | |
| VPKTASTSFTNIAYD | 81 | Q7LGA3 | |
| SEDYSQPSTSSSIIY | 391 | Q00987 | |
| QPSTSSSIIYSSQED | 396 | Q00987 | |
| YEVPQLLSSVAESSS | 706 | Q7Z3Z4 | |
| SLFTLASIYTTPDDS | 21 | A0A1B0GVY4 | |
| SYSSIQPEEYSSVVS | 536 | Q86V20 | |
| TSATEPYDLSFSRSF | 276 | Q6ZSJ9 | |
| YSTTFQESASTPETR | 231 | Q8WW24 | |
| STIITLYNGAFDSSS | 156 | Q8NBI5 | |
| SYEDSLTIAQAPSST | 531 | Q75T13 | |
| SHSYSPITVESDFSN | 881 | Q6UXD5 | |
| PFTYENTDESTNSSS | 1646 | Q9UHV7 | |
| DLDTTPYSSTVSEYS | 1126 | A1L4H1 | |
| STFPKASSESSYLSI | 556 | Q86SQ0 | |
| FFTLNSTPSRSAYDE | 186 | Q8NCY6 | |
| YLQDSLATTPASSSI | 951 | P36956 | |
| YFTEDSSSEASPLAS | 946 | Q66K14 | |
| VSVPSQSSASSDKYA | 361 | P52594 | |
| QSTTYPVYTESTDDK | 1071 | P25054 | |
| SYSFSSLENTVKTPS | 656 | G9CGD6 | |
| ATESAELTYISSSPD | 486 | Q8NB49 | |
| SLVSEQLEPAATSTY | 196 | Q9Y446 | |
| TSVSSLEAEAYAAFP | 116 | O95863 | |
| LQDPYSTTFSSFSRV | 216 | Q9HA65 | |
| ATEEYPSVSTLSDQS | 1001 | O95625 | |
| SASPAVTKDQYSATS | 1346 | Q96RL7 | |
| SPENDSIYSTQASIL | 846 | O75970 | |
| LFPSSLESSSEQKFY | 381 | Q8IUC6 | |
| SNLFSFSSTFEDPST | 556 | Q9NZV5 | |
| DLTSVPNLFTYSSFN | 196 | Q92753 | |
| DQPSTSQIAYTSLSL | 371 | P56693 | |
| SSVKTNSPAYSDISD | 836 | O15014 | |
| DSSEITFDSDIPLYS | 786 | Q9HCK1 | |
| ENTSSSPIQYEFSLT | 41 | P04216 | |
| APFRSYVDTASFTQS | 161 | Q13398 | |
| NTYLTGDQFSSESSL | 336 | P19174 | |
| VPTDSAVTVSSYAYT | 1771 | O43151 | |
| TFASTEGQYLLDTST | 131 | P30408 | |
| ISYQSDIPSSLLTSE | 781 | Q8NF64 | |
| IQTSFYELPTDSHAS | 71 | Q9Y5L0 | |
| NDKSLQTTFEYPSES | 581 | Q4KMQ1 | |
| APSSYSLQQASVLSE | 581 | Q9ULC8 | |
| DRSSLTSLETSYFTP | 441 | Q9UI33 | |
| FFFSASLPTNTTSSE | 931 | Q6R2W3 | |
| SLPTNTTSSELYEAV | 936 | Q6R2W3 | |
| EVSSADNVSVYPSVS | 1336 | Q5VWN6 | |
| VYSQESLTSSLSTTP | 1026 | Q9Y4F4 | |
| STSEIVVSSTALYPS | 1436 | Q9H4A3 | |
| ALYPSVTVSATSASA | 1446 | Q9H4A3 | |
| PLETSSYVSFASDQQ | 481 | Q6UX68 | |
| TTFLPSSKSDQYAIS | 411 | Q9H6R7 | |
| SGESQTTYSTFSAPL | 441 | Q9H6R7 | |
| VTTSRTFYVQADSPE | 261 | Q9HB21 | |
| FANDTIPSESYISAV | 1251 | Q5T4S7 | |
| FTSSLSTINYDEFPT | 351 | Q04206 | |
| TTSPSYTNTAFDVLL | 186 | P15822 | |
| QSLEVPSTTALESYN | 671 | P18583 | |
| TLTDDSDTPTFYQTL | 171 | Q8NFA0 | |
| DFSTVIDTPAANYLS | 461 | O95405 | |
| FKSLFPSSQTYSEDS | 406 | Q5TIE3 | |
| SDPFTTFSDYGVSVT | 186 | Q9UKN1 | |
| SLYSQAESTHTTAFP | 4911 | Q9UKN1 | |
| SAEASTYEVLLSFPS | 96 | Q9UQQ1 | |
| SLESDSNYPSISTSE | 1106 | Q9ULV0 | |
| SLSVTSDYSSSLERP | 1381 | Q5VU43 |